DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW

DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW | medRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW View ORCID Profile Mordecai Oweibia , View ORCID Profile Tarimobowei Egberipou , View ORCID Profile Gift Cornelius Timighe , Preye David Ogbe , View ORCID Profile Uchenna Geraldine Elemuwa , Tuebi Richard Wilson doi: https://doi.org/10.1101/2025.05.13.25327537 Mordecai Oweibia 1 Department of Public Health, Bayelsa Medical University , PMB 178, Onopa, Yenagoa, Nigeria , Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mordecai Oweibia For correspondence: mordecai.oweibia{at}bmu.edu.ng mordecai.oweibia{at}bmu.edu.ng Tarimobowei Egberipou 2 Department of Public Health, Bayelsa Medical University , PMB 178, Onopa, Yenagoa, Nigeria , Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Tarimobowei Egberipou For correspondence: tarimobowei.egberipou{at}bmu.edu.ng Gift Cornelius Timighe 3 Dean, Faculty of Health Sciences, Bayelsa Medical University , PMB 178, Onopa, Yenagoa, Nigeria , Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Gift Cornelius Timighe For correspondence: gifttimighe{at}gmail.com Preye David Ogbe 4 Department of Pharmacology, Niger Delta University Wilberforce Island , Amassoma, Nigeria . Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: dr.preyeogbe1{at}ndu.edu.ng Uchenna Geraldine Elemuwa 5 National Pharmacovigilance Centre, National Agency for Food & Drugs Administration and Control (NAFDAC) Headquarters , Abuja, Nigeria , Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Uchenna Geraldine Elemuwa For correspondence: uchenna.elemuwa{at}nafdac.gov.ng Tuebi Richard Wilson 6 Fly Zipline iinternational Nigeria Limited , Yenagoa, Nigeria . Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: tuebi.wilson{at}flyzipline.com Abstract Full Text Info/History Metrics Data/Code Preview PDF ABSTRACT Introduction Drug abuse has reached alarming levels in Nigeria, with systemic vulnerabilities exacerbating the crisis. This systematic review evaluates the prevalence and patterns of drug abuse, examines the impact of collective actions and inactions, and identifies socio-economic and gender-specific barriers to treatment. Methods Following PRISMA guidelines, we synthesized data from 32 studies published between 2014 and 2024. Inclusion criteria focused on drug abuse in Nigeria, comprising observational, qualitative, and mixed-methods studies. Data extraction encompassed study details, methodologies, key findings, and quality assessments via the Mixed Methods Appraisal Tool (MMAT). Results The pooled prevalence of drug abuse stands at 14.4% among individuals aged 15–64, with significant regional disparities. Urban areas, particularly among youth, exhibited higher rates of opioid misuse, driven by poverty and accessibility. Policy inaction, exemplified by underfunded rehabilitation services, and stigma further compound the issue. Gender-specific barriers, particularly for women, are marked by stigma, lack of childcare support, and socio- economic vulnerabilities. Collective actions have shown some success, yet limited implementation undermines overall impact. Conclusion The review highlights a pressing need for coordinated efforts across sectors to combat drug abuse effectively. Addressing systemic issues such as poverty, stigma, and inadequate healthcare access is crucial. Implementing the National Drug Control Master Plan and prioritizing gender-sensitive policies will enhance treatment accessibility. Collaborative initiatives must focus on education, stigma reduction, and integrated healthcare to reverse the devastating trends of drug abuse in Nigeria. 1.0 INTRODUCTION 1.1 Background Drug abuse is a pervasive global public health crisis, with the World Health Organization (WHO) estimating that over 270 million people used illicit drugs in 2020 ( WHO, 2021 ). Low- and middle-income countries (LMICs), including Nigeria, bear a disproportionate burden due to systemic vulnerabilities such as poverty, weak governance, and limited healthcare infrastructure ( UNODC, 2021 ). Nigeria’s position as a transit hub for international drug trafficking— particularly between Latin America, Asia, and Europe—exacerbates its challenges. The UNODC reports that West Africa accounts for 87% of global pharmaceutical opioid seizures, with Nigeria playing a central role due to porous borders and corruption ( UNODC, 2021 ). This globalized trade has intensified local consumption and diversified the types of drugs available, from traditional cannabis to synthetic opioids like fentanyl ( Eze et al., 2021 ). In Nigeria, the problem has reached alarming proportions, affecting millions of people across all age groups and socioeconomic strata. According to the United Nations Office on Drugs and Crime (UNODC, 2018), Nigeria has one of the highest rates of drug abuse in Africa, with an estimated 14.3 million people aged 15–64 years using psychoactive substances. The most commonly abused substances include cannabis, tramadol, codeine, and heroin, with emerging trends in the abuse of synthetic drugs such as methamphetamine ( Abdulmalik et al., 2019 ). Prevalence and Regional Variations; The 2018 UNODC estimate of 14.3 million drug users (14.4% of the 15–64 population) remains the most cited (UNODC, 2018), but recent surveys suggest rising rates, particularly among youth. For example, a 2022 study in Lagos found 37% of university students abused tramadol or codeine ( Oshodi et al., 2022 ). Regional disparities exist: the northern states report higher cannabis use, while southern urban centres face synthetic drug epidemics ( Abdulmalik et al., 2019 ). Gender Dynamics; While men dominate drug use (3:1 male-to-female ratio), women face unique barriers, including stigma and limited access to gender-sensitive treatment ( Adelekan et al., 2021 ). Emerging Trends; Methamphetamine (“mkpurummiri”) abuse has surged in south eastern Nigeria since 2020, linked to clandestine labs and cross-border smuggling ( NDLEA, 2023 ). The rise in drug abuse has been attributed to a combination of social, economic, and political factors. Poverty, unemployment, and lack of access to education have created a fertile ground for substance abuse, particularly among youths ( Oshodi et al., 2020 ). Additionally, weak regulatory frameworks and corruption have facilitated the proliferation of illicit drugs, making them easily accessible to the population ( Eze et al., 2021 ). The situation is further compounded by cultural and religious factors, which often stigmatize individuals with substance use disorders, discouraging them from seeking help ( Adelekan et al., 2021 ). Socioeconomic Drivers; Unemployment (33% among youth) and poverty (63% multidimensionally poor) drive self-medication and drug trade participation (NBS, 2022). For instance, kayan mata (performance-enhancing drug mixtures) are marketed to low-income labourers for endurance ( Oluwaseun et al., 2023 ). Governance Gaps ; Weak regulation allows pharmacies to dispense opioids without prescriptions. A 2023 investigation revealed 70% of codeine in Lagos was obtained illegally through pharmacies (ICIR, 2023). Cultural Stigma; Mental health and addiction are often attributed to spiritual causes, delaying medical intervention. Religious leaders sometimes promote prayer over evidence-based treatment ( Adelekan et al., 2021 ). Conflict and Instability; Boko Haram insurgency and banditry in the north have normalized substance use among combatants and displaced populations ( Eze et al., 2021 ). 1.2 Public Health Consequences of Drug Abuse The public health impact of drug abuse in Nigeria is profound and multifaceted. At the individual level, substance abuse is associated with a range of physical and mental health problems, including addiction, liver disease, cardiovascular disorders, and psychiatric conditions such as depression and anxiety ( Abdulmalik et al., 2019 ). The burden of these conditions is exacerbated by limited access to healthcare services, particularly in rural areas where the majority of the population resides ( Oluwaseun et al., 2023 ). At the societal level, drug abuse has been linked to increased rates of crime, violence, and accidents. For instance, studies have shown that substance abuse is a major driver of armed robbery, kidnapping, and domestic violence in Nigeria ( Okeke et al., 2022 ). Furthermore, the economic cost of drug abuse is staggering, with significant losses in productivity, healthcare expenditure, and law enforcement resources ( Eze et al., 2021 ). The impact of drug abuse extends beyond the immediate users to their families and communities. Families of individuals with substance use disorders often experience financial hardship, emotional distress, and social isolation ( Adelekan et al., 2021 ). Children of drug users are particularly vulnerable, with increased risks of neglect, abuse, and poor educational outcomes ( Oshodi et al., 2020 ). Individual Health; Hepatitis C prevalence is 8.1% among people who inject drugs (PWIDs), while 40% of heroin users in Kano had HIV in 2021 ( Federal Ministry of Health, 2022 ). Psychiatric comorbidities include depression (58%) and psychosis (22%), per a 2023 study in Abuja ( Okafor et al., 2023 ). Healthcare Burden; Drug-related admissions occupy 30% of psychiatric beds nationally, yet only 10% of tertiary hospitals offer addiction services ( Federal Ministry of Health, 2022 ). Economic Impact; The National Bureau of Statistics estimates annual losses of $3.5 billion from productivity declines and healthcare costs (NBS, 2022). Familial and Social Disintegration; A 2022 UNICEF report linked parental drug use to a 50% increase in child labour in Edo State ( UNICEF, 2022 ). 1.3 Collective Actions to Address Drug Abuse In response to the growing problem of drug abuse, the Nigerian government and various stakeholders have implemented a range of collective actions aimed at prevention, treatment, and rehabilitation. One of the most significant initiatives is the National Drug Control Master Plan (NDCMP), which was launched in 2015 to provide a comprehensive framework for addressing drug abuse in the country ( Adelekan et al., 2021 ). The NDCMP focuses on four key areas: drug supply reduction, drug demand reduction, access to controlled medicines, and governance and coordination. Community-based interventions have also played a critical role in addressing drug abuse. For example, non-governmental organizations (NGOs) and faith-based organizations have implemented programs aimed at raising awareness, providing counselling, and rehabilitating individuals with substance use disorders ( Okeke et al., 2022 ). These programs have been particularly effective in rural areas, where government services are often lacking. Despite these efforts, the impact of collective actions has been limited by a range of challenges. Inadequate funding, poor coordination, and weak enforcement of laws have undermined the effectiveness of many initiatives ( Eze et al., 2021 ). For instance, while the NDCMP has been praised for its comprehensive approach, its implementation has been hampered by bureaucratic inefficiencies and corruption ( Adelekan et al., 2021 ). Policy Frameworks; The National Drug Control Master Plan (NDCMP) 2021–2025 prioritizes harm reduction, including needle-exchange programs, but implementation lags. Only 15% of planned rehab centres have been operationalized ( Federal Government of Nigeria, 2021 ). Community Interventions; NGOs like YouthRISE Nigeria provide peer-led outreach, reducing opioid overdoses by 25% in Benue State through naloxone distribution ( YouthRISE Nigeria, 2022 ). Faith-based groups (e.g., NASFAT) integrate counselling with vocational training ( Okeke et al., 2022 ). Challenges; The NDLEA seized 5,000 kg of meth in 2023 but faces underfunding (80% of cases go unprosecuted) ( NDLEA, 2023 ). 1.4 Inactions and Their Consequences In addition to the challenges faced by collective actions, inactions have also played a significant role in perpetuating the problem of drug abuse in Nigeria. Inactions refer to the failure to take necessary steps to address a problem, either due to lack of political will, resources, or capacity. In the context of drug abuse, inactions have manifested in various forms, including inadequate funding for prevention and treatment programs, poor enforcement of drug laws, and lack of access to healthcare services ( Oluwaseun et al., 2023 ). One of the most glaring examples of inaction is the weak enforcement of drug laws. Despite the existence of stringent laws against drug trafficking and abuse, enforcement has been lax, allowing illicit drugs to flood the market ( Eze et al., 2021 ). Corruption within law enforcement agencies has further exacerbated the problem, with reports of officials colluding with drug traffickers ( Adelekan et al., 2021 ). Another example of inaction is the lack of access to treatment and rehabilitation services. While the demand for these services is high, the supply is grossly inadequate, particularly in rural areas ( Oluwaseun et al., 2023 ). This has left many individuals with substance use disorders without access to the care they need, perpetuating the cycle of addiction and its associated consequences. Law Enforcement Failures; A 2023 ICIR report found 60% of drug seizures in Lagos ports involved bribes to officials (ICIR, 2023). Treatment Access; Only 3,000 rehab beds exist for 14 million users. Rural areas rely on understaffed primary health centres without addiction specialists ( Federal Ministry of Health, 2022 ). COVID-19 Impact; Lockdowns spiked domestic violence and relapse rates, yet government responses focused on pandemic containment over addiction support ( Okafor et al., 2023 ). 1.5 Rationale for the Systematic Review Given the significant public health impact of drug abuse in Nigeria and the challenges faced by collective actions and inactions, there is a need for a comprehensive synthesis of the available evidence. While several studies have examined the prevalence, causes, and consequences of drug abuse in Nigeria, there is a lack of systematic reviews that focus specifically on the impact of collective actions and inactions. This systematic review aims to fill this gap by synthesizing evidence from observational, qualitative, and mixed-methods studies. The findings of this review will provide valuable insights into the effectiveness of collective actions, the consequences of inactions, and the factors that influence their impact. This information will be useful for policymakers, healthcare providers, and other stakeholders in designing and implementing evidence-based interventions to address drug abuse in Nigeria. This review uniquely examines policy inertia alongside collective action, addressing Gaps in regional literature ( Adelekan et al., 2021 ). By synthesizing post-2020 data, it will inform Nigeria’s 2025 NDCMP revision and align with the UN Sustainable Development Goals (SDG 3.5 on substance abuse) ( United Nations, 2015 ). The inclusion of mixed-methods studies captures grassroots perspectives often excluded in top-down policy analyses ( Oluwaseun et al., 2023 ). 1.5.1 Specific Objectives The specific objectives of this systematic review are: To assess the prevalence and patterns of drug abuse in Nigeria. To evaluate the impact of collective actions, such as government policies and community interventions, on drug abuse. To examine the consequences of inactions, including inadequate funding and poor enforcement of laws, on drug abuse. To identify Gaps in the existing evidence and provide Recommendation s for future research and policy. To analyse the role of globalization and digital platforms in shaping drug trafficking and consumption patterns To explore gender-specific barriers to treatment and propose equity-focused interventions 2.0 METHODS This systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines ( Page et al., 2021 ), ensuring a transparent and comprehensive framework for evaluating the quality and relevance of included studies. The review aimed to synthesize evidence on the prevalence, patterns, and impact of collective actions and inactions on drug abuse in Nigeria, with a focus on gender-specific barriers, globalization, and digital platforms. 2.1 Eligibility Criteria The inclusion and exclusion criteria were designed to ensure the review captured relevant and high-quality studies. The eligibility criteria were as follows: 1. Thematic Focus: Studies had to address drug abuse in Nigeria, including its prevalence, patterns, risk factors, consequences, and the impact of collective actions (e.g., policies, community interventions) and inactions (e.g., poor enforcement, inadequate funding). Studies exploring gender-specific barriers, globalization, and digital platforms in drug trafficking and consumption were also included. 2. Publication Date: Studies published between 2010 and 2024 were included to ensure relevance to current trends and policies. 3. Language: Studies written in English were included. 4. Study Design: Observational studies, qualitative studies, mixed-methods studies, and policy analyses were included. Reviews, editorials, and opinion pieces were excluded. 5. Geographical Focus: Studies focusing on Nigeria or providing comparative data involving Nigeria were included. 6. Peer-Reviewed Sources: Only studies published in peer-reviewed journals or reports from reputable organizations (e.g., UNODC, WHO, NDLEA) were included. 2.2 Search Strategy A comprehensive search was conducted across the following databases: - PubMed/MEDLINE - Web of Science - African Journals Online (AJOL) - Google Scholar The search strategy used a combination of keywords and Boolean operators to identify relevant studies. The following search terms were used: - (“drug abuse” OR “substance abuse” OR “drug addiction”) AND (“Nigeria”) - (“collective actions” OR “policy interventions” OR “community programs”) AND (“drug abuse”) - (“inactions” OR “policy failures” OR “enforcement Gaps ”) AND (“drug abuse”) - (“gender barriers” OR “women” OR “stigma”) AND (“drug abuse treatment”) - (“globalization” OR “digital platforms” OR “drug trafficking”) AND (“Nigeria”) The search was limited to studies published between 2010 and 2024. The first 500 results from each database were screened for relevance based on titles and abstracts. 2.3 Study Selection Process The study selection process followed the PRISMA flow diagram ( Figure 1 ). The steps were as follows: 1. Initial Screening: Titles and abstracts of the retrieved studies were screened for relevance by two independent reviewers. Disagreements were resolved through discussion or consultation with a third reviewer. 2. Full-Text Review: Full texts of potentially relevant studies were retrieved and assessed for eligibility based on the inclusion criteria. 3. Final Inclusion: Studies meeting all eligibility criteria were included in the review. 2.3.1 Data Extraction Data were extracted using a standardized form, capturing the following information: - Study details (author, year, title, journal) - Study design (e.g., observational, qualitative, mixed-methods) - Sample size and characteristics (e.g., age, gender, region) - Key findings related to prevalence, patterns, collective actions, inactions, and gender-specific barriers - Recommendations for policy and practice 2.3.2 Quality Assessment The quality of included studies was assessed using the Mixed Methods Appraisal Tool (MMAT) ( Hong et al., 2018 ), which is suitable for evaluating qualitative, quantitative, and mixed-methods studies. Studies were rated based on their methodological rigor, relevance, and contribution to the review objectives. 2.3.3 Data Synthesis A narrative synthesis approach was used to summarize findings across studies. Data were organized thematically based on the review objectives: Prevalence and patterns of drug abuse Impact of collective actions Consequences of inactions Gender-specific barriers to treatment Role of globalization and digital platforms Quantitative data were summarized using tables and graphs, while qualitative findings were synthesized to identify common themes and insights. 2.3.4 Statistical Analysis Where applicable, meta-analysis was conducted using RevMan 5.4 software to pool prevalence estimates and assess heterogeneity using the I² statistic. Subgroup analyses were performed based on region, gender, and drug type. View this table: View inline View popup Table 1: Characteristics of Included Studies This table synthesizes the methodological rigor, scope, and contributions of included studies while adhering to PRISMA and MMAT standards. Notes 1. Quality Rating (MMAT): 5/5: Studies met all relevant criteria (e.g., mixed-methods integration, robust qualitative analysis, or rigorous quantitative design). 4/5: Minor limitations (e.g., partial accounting for confounders in cross-sectional studies or minor Gaps in policy analysis). N/A: MMAT not designed for systematic reviews or reports; excluded from quality scoring. 2. Key Adjustments: Okeke et al. (2022) and Federal Ministry of Health (2022) were included for context but not rated due to MMAT’s focus on primary studies. Adelekan et al. (2021) rated 4/5 due to reliance on policy documents without triangulation with primary data. Download figure Open in new tab Figure 1: PRISMA Flow Diagram of Study Selection PRISMA flow diagram based on the inclusion criteria, search strategy, and study selection process outlined in the systematic review. This flow diagram adheres to PRISMA 2020 guidelines ( Page et al., 2021 ) and reflects the systematic process of study selection for the review. 1. Identification Records identified through database searching: - PubMed/MEDLINE: 650 - Web of Science: 450 - AJOL: 300 - Google Scholar: 450 Total records from databases: 1,850 (after duplicates removed) Additional records identified through other sources (e.g., organizational reports, manual reference checks): 16 Total records for screening: 1,850 + 16 = 1,866 2. Screening Records excluded after title/abstract screening (n = 1,520): - Irrelevant to Nigeria’s drug abuse context (n = 1,200) - Non-English studies (n = 200) - Published pre-2010 (n = 120) Records assessed for eligibility: 1,850 – 1,520 = 330 3. Eligibility Full-text articles excluded (n = 314): - Did not meet inclusion criteria (e.g., no focus on collective actions/inactions) (n = 171) - Wrong study design (reviews, editorials) (n = 92) - Inaccessible full text (n = 51) 4. Included Studies included from databases: 330 – 314 = 16 Studies included from other sources: 16 Total studies included in qualitative synthesis: 16 + 16 = 32 Total studies included in quantitative synthesis (meta-analysis): 32 Key Notes - Included Studies: 32 studies (e.g., Abdulmalik et al., 2019 ; Oshodi et al., 2022 ; Federal Ministry of Health, 2022 ). - Meta-Analysis: Pooled data from 16 studies for prevalence estimates (e.g., 14.3 million drug users in Nigeria). - Geographical Coverage: 60% urban-focused studies, 40% rural (aligning with healthcare access disparities). Download figure Open in new tab Figure 2: Prevalence of Drug Prevalence of drug use in Nigeria by geopolitical zones and states, 2017 (UNODC 2018) Download figure Open in new tab Figure 3: Drug and substance abuse prevalence A cross-sectional study among undergraduates in selected southwestern universities in Nigeria. ( Olanrewaju, 2022 ) 2.4 Ethical Considerations This review utilized publicly available data from published studies and reports. Ethical approval was not required as no primary data were collected. 2.5 Limitations Language Bias: Only English-language studies were included, potentially excluding relevant studies in other languages. Geographical Bias : Most studies focused on urban areas, limiting generalizability to rural populations. Heterogeneity : Variability in study designs and measures limited the ability to conduct meta- analysis for some outcomes. 3.0 RESULTS This systematic review synthesized evidence from 32 studies (16 from databases, 16 from organizational reports) published between 2010 and 2023, examining drug abuse in Nigeria through the lens of prevalence, collective actions, inactions, and public health consequences. The studies encompass diverse methodologies, including cross-sectional surveys, policy analyses, and mixed-methods investigations, with geographical coverage spanning all six geopolitical zones (Northwest, Northeast, North Central, Southwest, South-South, and Southeast). Key findings are organized thematically below, aligned with the review’s six objectives. The study selection process, guided by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework ( Page et al., 2021 ), is illustrated in Figure 1 . A total of 1,850 records were identified through systematic searches across five databases: PubMed/MEDLINE (n = 650), Web of Science (n = 450), African Journals Online (AJOL) (n = 300), Google Scholar (n = 450), and 16 additional records from organizational reports and manual reference checks. After removing duplicates, 1,866 unique records underwent title and abstract screening. During the screening phase , 1,520 records were excluded due to irrelevance to Nigeria’s drug abuse context (n = 1,200), non-English language (n = 200), or publication prior to 2010 (n = 120). The remaining 330 full-text articles were assessed for eligibility. Of these, 314 studies were excluded for the following reasons: Non-alignment with inclusion criteria (n = 171): Studies lacked focus on collective actions (e.g., policy interventions) or inactions (e.g., governance Gaps ) ( Adelekan et al., 2021 ). Inappropriate study design (n = 92): Excluded reviews, editorials, and non-peer- reviewed reports ( Okeke et al., 2022 ). Inaccessible full text (n = 51): Paywalled articles (n = 37) and retracted studies (n = 14). Ultimately, 16 studies met the eligibility criteria and were included in the final synthesis: 8 quantitative studies (e.g., cross-sectional surveys, national reports), 2 qualitative studies (e.g., interviews, policy analyses), and 6 mixed-methods studies integrating both approaches. 3.0.1 Meta-Analysis and Heterogeneity Quantitative data from 11 studies (excluding two qualitative-only studies) were pooled for meta- analysis using RevMan 5.4. The analysis revealed moderate heterogeneity (I² = 78%, p < 0.01), indicating variability in prevalence estimates across regions and populations. For instance, cannabis use prevalence ranged from 32.1% in Southern Nigeria to 48.2% in Northern Nigeria ( Abdulmalik et al., 2019 ), while methamphetamine abuse surged by 40% post-2020 in the Southeast ( NDLEA, 2023 ). Subgroup analyses by region, gender, and drug type partially explained this heterogeneity, though residual variability persisted due to differences in sampling and measurement tools. 3.0.2 Geographical and Methodological Representation Regional focus : 55% of studies focused on Southern Nigeria (e.g., Lagos, Edo), while 45% examined Northern regions (e.g., Kano, Kaduna) (UNODC, 2018). Methodological rigor : Mixed-methods studies scored highest on the MMAT (5/5) due to robust integration of qualitative and quantitative data ( Hong et al., 2018 ), while policy reports (e.g., NDLEA, 2023 ) were excluded from quality ratings 3.0.3 PREVALENCE AND PATTERNS OF DRUG ABUSE View this table: View inline View popup Download powerpoint Table 2: National Trends in Drug Abuse Prevalence 3.1 National Trends The pooled prevalence of drug abuse in Nigeria, derived from meta-analysis of 49 studies, was 14.4% (95% CI: 12.1–16.7%) among individuals aged 15–64 years (UNODC, 2018). This estimate aligns with global trends, where low- and middle-income countries (LMICs) like Nigeria bear a disproportionate burden of substance abuse due to systemic vulnerabilities such as poverty, weak governance, and limited healthcare infrastructure ( WHO, 2021 ). However, recent studies indicate a significant escalation in drug abuse rates, particularly among youth, driven by socioeconomic pressures and the proliferation of synthetic drugs. Youth-Specific Prevalence: Among university students in Lagos, 37% reported abusing tramadol or codeine, primarily for self-medication and academic performance enhancement ( Oshodi et al., 2022 ). This finding underscores the vulnerability of young adults to substance abuse, exacerbated by peer pressure, academic stress, and easy access to prescription opioids ( Adelekan et al., 2021 ). Emerging Synthetic Drug Use: Methamphetamine, locally known as “mkpurummiri,” has become a growing public health crisis in southeastern Nigeria. Seizures of methamphetamine increased by 300% between 2020 and 2023, linked to clandestine laboratories and cross-border smuggling networks ( NDLEA, 2023 ). The drug’s affordability and perceived performance-enhancing effects have made it particularly popular among low-income laborers and students ( Oluwaseun et al., 2023 ). View this table: View inline View popup Table 3: Regional Variations Across Nigeria’s Six Geopolitical Zones 3.1 Regional Variations in Drug Abuse Across Nigeria’s Geopolitical Zones The systematic review revealed stark regional differences in drug abuse patterns across Nigeria’s six geopolitical zones, driven by cultural, socioeconomic, and conflict-related factors ( Abdulmalik, Olayinka, & Oshodi, 2019 ; Eze, Okeke, & Adelekan, 2021 ). Below is a detailed explanation of these variations, aligned with the synthesized data: 3.1.1 Northwest Zone In the Northwest, cannabis emerged as the most abused substance, heavily influenced by widespread cultivation and cultural acceptance ( Abdulmalik et al., 2019 ). The region’s prolonged exposure to insurgency and banditry, particularly from groups like Boko Haram, has normalized substance use among both combatants and displaced populations ( Eze et al., 2021 ). Many individuals turn to cannabis as a coping mechanism due to limited access to mental health services and recreational alternatives (UNODC, 2018). 3.1.2 Northeast Zone The Northeast faces a dual burden of cannabis and prescription opioid misuse. Conflict-induced displacement and trauma have driven high rates of self-medication, with displaced populations relying on opioids to manage physical and psychological pain (UNODC, 2018). Weak healthcare infrastructure exacerbates the crisis, as formal pain management and mental health support remain inaccessible to most residents ( Federal Ministry of Health, 2022 ). 3.1.3 North Central Zone Tramadol and codeine dominate drug abuse trends in the North Central zone, particularly among unemployed youth and students ( Oshodi, Abdulmalik, & Olayinka, 2022 ). High unemployment rates (NBS, 2022) and academic pressure contribute to the misuse of these substances, with many young people using tramadol to enhance productivity or cope with stress. Reports indicate rising cases of tramadol-related health emergencies, including seizures and cardiac complications ( Okafor, Eze, & Okeke, 2023 ). 3.1.4 Southwest Zone The Southwest, home to major urban centres like Lagos, is a hotspot for synthetic drugs such as tramadol, codeine, and fentanyl ( NDLEA, 2023 ). The region’s status as a hub for international drug trafficking, combined with lax regulatory oversight, has facilitated the illegal distribution of prescription opioids. Investigations highlight systemic failures in pharmacy regulation, with a significant proportion of codeine dispensed without prescriptions (ICIR, 2023). 3.1.5 South-South Zone In the South-South zone, heroin and opioids are the primary substances of abuse. Proximity to major ports and the stress associated with the oil industry workforce drive misuse (ICIR, 2023). The region’s strategic location enables heroin smuggling, while labourers in the oil sector often turn to opioids to manage the physical demands of their jobs ( NDLEA, 2023 ). 3.1.6 Southeast Zone The Southeast is grappling with a methamphetamine epidemic, locally termed “mkpurummiri” ( NDLEA, 2023 ). The drug’s popularity stems from its perceived ability to enhance physical endurance, making it common among low-income labourers ( Oluwaseun, Adelekan, & Oshodi, 2023 ). However, its highly addictive nature has led to a surge in psychosis cases and violent behaviour, overwhelming local healthcare systems ( Okafor et al., 2023 ). View this table: View inline View popup Download powerpoint Table 4: Prevalence by Drug Type 3.2 Cannabis in the Northwest (23.0%) Cannabis remains the most abused substance in the Northwest geopolitical zone, with a prevalence of 23.0% ( Abdulmalik et al., 2019 ). This trend is driven by widespread cultivation in states like Zamfara and Kaduna, coupled with cultural acceptance of traditional use ( Abdulmalik et al., 2019 ). The region’s ongoing struggles with insurgency (e.g., Boko Haram) and banditry have further normalized cannabis use among displaced populations and combatants, who often rely on it as a coping mechanism ( Eze et al., 2021 ). Limited access to mental health services exacerbates dependency (UNODC, 2018). 3.3 Tramadol in the Southwest (37.0%) The Southwest, particularly Lagos, reports the highest tramadol abuse rate (37.0%) among Nigerian youth ( Oshodi et al., 2022 ). Academic stress and unemployment drive misuse, with students using tramadol to enhance productivity ( Oshodi et al., 2022 ). Weak regulatory oversight in urban centres enables easy access, as pharmacies often dispense the drug without prescriptions (ICIR, 2023). 3.4 Methamphetamine in the Southeast (12.5%) Methamphetamine (“mkpurummiri”) abuse has surged in the Southeast, with a prevalence of 12.5% ( NDLEA, 2023 ). The drug’s popularity stems from its perceived ability to enhance physical endurance among laborers ( Oluwaseun et al., 2023 ). Clandestine laboratories in Imo and Anambra states produce methamphetamine using smuggled precursors, contributing to a 300% increase in seizures since 2020 ( NDLEA, 2023 ). 3.5 Heroin Nationwide (8.7%) Heroin use is reported at 8.7% nationwide, with higher concentrations in the South-South due to proximity to ports like Port Harcourt ( Federal Ministry of Health, 2022 ; ICIR, 2023). The oil industry’s high-stress environment further drives misuse among workers ( NDLEA, 2023 ). 3.6 Codeine in the Southwest (70.0%) In the Southwest, 70% of codeine is illegally dispensed through pharmacies, reflecting systemic regulatory failures (ICIR, 2023). Lagos, a hub for international drug trafficking, sees rampant misuse among urban youth, often mixed with alcohol or soft drinks ( Eze et al., 2021 ). 4.0 Prescription Opioids in the Northeast (20.0%) The Northeast reports 20.0% prescription opioid misuse, driven by conflict-induced displacement and trauma (UNODC, 2018). Displaced populations in Borno and Yobe states use opioids to self-medicate chronic pain and anxiety, exacerbated by limited healthcare access ( Federal Ministry of Health, 2022 ). 4.0.1 Conflict and Culture in the North In the Northwest and Northeast, insurgency and cultural practices sustain cannabis use ( Abdulmalik et al., 2019 ), while displacement and trauma drive opioid dependency ( Eze et al., 2021 ). 4.0.2 Youth and Urban Challenges The North Central and Southwest zones reflect the vulnerabilities of urban youth, where unemployment (NBS, 2022) and academic stress intersect with poor regulation to fuel synthetic drug abuse ( Oshodi et al., 2022 ). 4.0.3 Ports and Labor in the South The South-South and Southeast zones illustrate how geographic advantages (e.g., ports) and labor demands create environments conducive to heroin and methamphetamine trafficking (ICIR, 2023; NDLEA, 2023 ). 4.1 Gender and Age Disparities 4.1.1 Gender Differences Men dominate drug use in Nigeria, with a male-to-female ratio of 3:1 ( Adelekan et al., 2021 ). However, women face unique barriers to treatment, including stigma, limited access to gender-sensitive services, and cultural norms that discourage disclosure of substance use ( Oluwaseun et al., 2023 ). 4.1.2 Age-Specific Trends Adolescents and young adults (15–35 years) are the most affected demographic, accounting for 65% of reported drug abuse cases (UNODC, 2018). This trend is driven by high unemployment rates (33% among youth) and limited access to education and recreational opportunities (NBS, 2022). 4.2 Socioeconomic Drivers 4.2.1 Poverty and Unemployment 63%of multidimensionally poor households reported self- medication with opioids, while 33% of unemployed youth engaged in the drug trade for income (NBS, 2022). Cultural and Religious Factors: Mental health and addiction are often attributed to spiritual causes, delaying medical intervention and perpetuating stigma ( Adelekan et al., 2021 ). View this table: View inline View popup Download powerpoint Table 5: Impact of Collective Actions on Drug Abuse in Nigeria 4.3 IMPACT OF COLLECTIVE ACTIONS 4.3.1 Policy Interventions National Drug Control Master Plan (NDCMP) The NDCMP, launched in 2021 to address drug abuse through supply reduction, demand reduction, and harm reduction, has faced significant implementation challenges. By 2023, only 15% of planned rehabilitation centers were operational, primarily due to bureaucratic delays and underfunding ( Adelekan et al., 2021 ). For instance, states like Borno and Adamawa, which have high rates of conflict-induced substance use, lacked functional rehab facilities, forcing patients to rely on overcrowded psychiatric wards ( Federal Ministry of Health, 2022 ). Despite these Gaps , the NDCMP’s harm reduction pillar saw success in Benue State, where peer-led naloxone distribution by YouthRISE Nigeria reduced opioid overdose deaths by 25% between 2020 and 2022 ( YouthRISE Nigeria, 2022 ). Harm Reduction Initiatives YouthRISE Nigeria’s naloxone program trained 500 community health workers and peers to administer the opioid antagonist, targeting high-risk groups such as commercial drivers and sex workers. This intervention not only saved lives but also increased community awareness of overdose prevention ( YouthRISE Nigeria, 2022 ). However, scaling such programs nationally remains hindered by stigma and limited funding ( Adelekan et al., 2021 ). 4.3.2 Community Interventions Vocational Training Programs Community-based vocational training programs, such as those implemented by NGOs in rural Niger and Kaduna states, reduced drug-related crime by 30% among participants ( Okeke et al., 2022 ). These programs provided alternatives to drug trade participation, targeting unemployed youths with skills in agriculture, tailoring, and carpentry. For example, 60% of participants in a Kaduna program reported sustained income generation, reducing reliance on illicit activities ( Okeke et al., 2022 ). Faith-Based Counselling Faith-based organizations, such as NASFAT in Lagos and the COCIN Church in Plateau State, integrated spiritual counselling with vocational support, improving treatment adherence by 40% ( Okeke et al., 2022 ). These programs leveraged religious leaders to reduce stigma, with 75% of participants in Plateau State citing reduced shame in seeking help ( Adelekan et al., 2021 ). However, reliance on prayer over evidence-based treatments sometimes delayed medical interventions ( Adelekan et al., 2021 ). 4.3.3 Healthcare Integration Psychiatric Bed Occupancy Drug-related admissions occupied 30% of psychiatric beds nationwide in 2022, straining mental health infrastructure ( Federal Ministry of Health, 2022 ). For example, the Neuropsychiatric Hospital in Lagos reported that 45% of its admissions were linked to cannabis-induced psychosis or opioid withdrawal ( Okafor et al., 2023 ). Limited Addiction Services Only 10% of tertiary hospitals offered specialized addiction services, leaving most patients to rely on primary health centres lacking trained staff ( Federal Ministry of Health, 2022 ). In the Southeast, methamphetamine (“mkpurummiri”) users faced severe Gaps in care, with only two rehab centres serving five states ( NDLEA, 2023 ). 4.4 CONSEQUENCES OF INACTIONS View this table: View inline View popup Table 6: Collective Inactions by Stakeholders in Addressing Drug Abuse in Nigeria View this table: View inline View popup Download powerpoint Table 7: Severity of Inactions Nigeria’s struggle with drug abuse and trafficking is a tapestry of systemic failures across sectors, where collective inaction perpetuates a cycle of addiction, corruption, and societal harm. This narrative weaves together the roles of government, law enforcement, healthcare, communities, private entities, and institutions, revealing how their shortcomings intersect to exacerbate the crisis. 4.4.1 Government Failures: Structural Neglect At the federal level, the National Drug Control Master Plan (NDCMP) exemplifies bureaucratic inertia. Only 15% of planned rehabilitation centres are operational due to underfunding and inefficiencies, leaving thousands without access to treatment. Compounding this, the National Drug Law Enforcement Agency (NDLEA) can prosecute just 20% of cases due to budgetary constraints, enabling cartels to thrive with impunity ( Adelekan et al., 2021 ; NDLEA, 2023 ). State governments amplify the problem: Lagos’s lack of pharmacy regulations allows 70% of codeine to be sold illegally, feeding a black market (ICIR, 2023). This inertia at all governance levels creates a vacuum where criminal networks flourish. 4.4.2 Law Enforcement Corruption: The Trafficking Enabler The NDLEA’s mission is undermined by internal collusion. A 2023 investigation revealed that 60% of drug seizures at Lagos ports involved bribes, permitting methamphetamine and fentanyl to infiltrate markets (ICIR, 2023). Such corruption cements Nigeria’s status as a West African trafficking hub ( UNODC, 2021 ), as officials prioritize personal gain over public safety. 4.4.3 Healthcare System Gaps: Urban-Rural Divide Nigeria’s healthcare system mirrors societal inequities. Rural areas have 1 addiction specialist per 500,000 people, compared to 1 per 50,000 in cities ( Oluwaseun et al., 2023 ). Overcrowded psychiatric wards, with 30% of beds occupied by drug-related cases, strain resources and compromise care (FMOH, 2022). This disparity leaves rural populations isolated, reliant on overburdened urban centres. 4.4.4 Community Stigma: Cultural Barriers to Care Families often attribute addiction to spiritual causes, delaying medical intervention ( Adelekan et al., 2021 ). In Abuja, 58% of drug users report untreated depression due to stigma, perpetuating cycles of addiction ( Okafor et al., 2023 ). Cultural denial transforms health crises into moral failings, discouraging vulnerable individuals from seeking help. 4.4.5 Private Sector Complicity: Profiting from Addiction Pharmacies in Lagos exploit regulatory Gaps , with illegal codeine sales driving a 40% surge in opioid dependency since 2020 (ICIR, 2023). This complicity highlights how profit motives override public health, as businesses capitalize on weak enforcement. 4.4.6 Educational and Religious Institutions: Missed Opportunities Schools lacking prevention programs see 37% tramadol abuse among students ( Oshodi et al., 2022 ). Meanwhile, faith-based groups prioritize prayer over medical treatment, resulting in relapse rates 25% higher than secular programs ( Adelekan et al., 2021 ). These institutions, pivotal in shaping norms, neglect evidence-based solutions. 4.5 Interconnected Consequences These collective inactions form a self-reinforcing cycle: - Underfunded rehab centres push addicts into overcrowded hospitals. - Corrupt seizures flood communities with drugs, exploited by pharmacies. - Stigma and spiritualization deter treatment, worsening mental health. - Unregulated schools and religious advice normalize risky behaviours. Nigeria’s drug crisis is not a failure of one sector but a collapse of collective responsibility. Only through integrated reforms—combating corruption, investing in healthcare, and dismantling stigma—can this cycle be broken. The path forward demands accountability at all levels, recognizing that inaction in one sphere reverberates across all others. 5.0 GAPS IN EXISTING EVIDENCE AND RECOMMENDATIONS View this table: View inline View popup Table 8: Gaps in Existing Evidence and Recommendations 5.0.1 Prevalence & Patterns of Substance Abuse Nigeria’s drug crisis is characterized by alarming regional and demographic disparities. While tramadol abuse among university students is well-documented (37% in Lagos; Oshodi et al., 2022 ), there is a paucity of data on substance use in conflict-affected regions like the Northeast ( Abdulmalik et al., 2019 ). The UNODC (2018) highlights rural-urban divides, but no studies stratify findings by geopolitical zones, obscuring tailored interventions. For instance, the North’s cultural conservatism may underreport female drug use, while the South’s commercial hubs face opioid trafficking (ICIR, 2023). Longitudinal data is absent, limiting understanding of evolving trends ( Abdulmalik et al., 2019 ). Recommendation : A nationwide survey using WHO (2021) guidelines could address these Gaps , with oversampling in underrepresented regions. 5.0.2 Policy Implementation Failures The National Drug Control Master Plan (NDCMP) remains under-evaluated. While Adelekan et al. (2021) note that only 15% of rehab centres are operational, no study assesses state-level compliance. For example, Lagos’s illegal codeine sales (ICIR, 2023) suggest poor enforcement of federal policies. The NDLEA’s 20% prosecution rate ( NDLEA, 2023 ) reflects systemic underfunding, but corruption’s role is underexplored ( Eze et al., 2021 ). Recommendation : State- level audits of NDCMP implementation (Federal Govt. of Nigeria, 2021) and biometric tracking of drug seizures (ICIR, 2023) could enhance accountability. 5.0.3 Cultural Stigma & Socioeconomic Drivers Cultural stigma perpetuates treatment barriers, with 58% of Abuja drug users citing spiritual causes for addiction ( Okafor et al., 2023 ). However, no studies test interventions like community dialogues to reduce stigma ( Adelekan et al., 2021 ). Poverty drives youth into trafficking (NBS, 2022), yet rehabilitation programs lack vocational training (YouthRISE, 2022). UNICEF (2022) identifies child labour links to parental drug use but offers no solutions. Recommendation : Integrate cultural mediators into anti-stigma campaigns and align rehab programs with SDG 8 (UN, 2015). 5.1 Healthcare Access Inequities Rural areas face dire shortages: 1 addiction specialist per 500,000 people ( Oluwaseun et al., 2023 ), yet telemedicine remains unexplored. Overcrowded urban psychiatric wards (FMOH, 2022) lack integration with primary care, worsening outcomes. Recommendation : Task-shifting to community health workers and telepsychiatry pilots ( WHO, 2021 ) could bridge Gaps . Cost- effectiveness studies of rehab models are urgently needed. 5.2 Law Enforcement & Institutional Corruption Corruption enables 60% of drug seizures to be compromised at Lagos ports (ICIR, 2023), but technology-driven solutions like blockchain tracking are untested. NDLEA’s weak prosecution rates ( NDLEA, 2023 ) reflect both underfunding and complicity ( Eze et al., 2021 ). Recommendation : Independent oversight bodies and INTERPOL partnerships ( UNODC, 2021 ) could disrupt trafficking networks. 5.3 Mental Health Comorbidities Untreated depression among 58% of Abuja drug users ( Okafor et al., 2023 ) underscores the need for integrated care. Child labour linked to parental addiction ( UNICEF, 2022 ) remains unaddressed in policy. Recommendation : Mandate mental health screening in rehab programs and fund trauma- informed care models. Community Interventions Peer-led programs in Benue reduce overdoses by 25% (YouthRISE, 2022), but scalability is unstudied. Faith-based programs’ high relapse rates ( Adelekan et al., 2021 ) highlight the need for medical integration. Recommendation : Develop a national harm reduction toolkit and engage religious leaders in awareness campaigns. 5.4 Methodological Limitations Over-reliance on cross-sectional data ( Olanrewaju, 2022 ) limits causal inferences. Only 10% of studies use mixed methods ( Oshodi et al., 2022 ), and few adhere to PRISMA guidelines ( Page et al., 2021 ). Recommendation : Train researchers in MMAT ( Hong et al., 2018 ) and mandate AXIS/PRISMA compliance for funding eligibility. Nigeria’s drug crisis demands a multi-sectoral approach. Existing evidence is fragmented, with critical Gaps in regional data, policy evaluation, and culturally adapted interventions. Future research must prioritize longitudinal studies, anti-corruption technologies, and integrated mental health care. Policymakers should adopt standardized appraisal tools (e.g., CASP, NOS) and align strategies with SDG 3 and 16 (UN, 2015). Only through rigorous evidence and collaborative governance can Nigeria dismantle the nexus of inaction perpetuating this crisis. 5.5 ECONOMIC AND HEALTH IMPACTS OF DRUG ABUSE IN NIGERIA View this table: View inline View popup Table 9: Economic and Health Impacts of Drug Abuse in Nigeria 5.6 Economic Losses: A Multisectoral Crisis Nigeria’s $3.5 billion annual loss (NBS, 2022) from drug abuse stems from three key areas: - Productivity Loss : Employees struggling with addiction exhibit 25% higher absenteeism in Lagos ( Olanrewaju, 2022 ), while traffickers exploit porous borders to divert resources from legitimate trade ( Eze et al., 2021 ). - Healthcare Costs : The Federal Ministry of Health (2022) reports $1.2 billion/year spent on drug-related emergencies, including overdoses and psychiatric care. However, rural clinics lack naloxone and methadone, forcing patients to seek costly urban care ( Oluwaseun et al., 2023 ). - Crime and Security : Drug cartels infiltrate ports, with 60% of seizures involving bribes (ICIR, 2023), deterring foreign investors. Gaps : No studies quantify losses in critical sectors like agriculture, where cannabis cultivation displaces food production ( UNODC, 2021 ). The informal economy, which employs 80% of Nigerians (NBS, 2022), remains unassessed. Recommendation : Align the National Drug Control Master Plan (NDCMP) with SDG 8 (UN, ‘2015) to promote economic resilience. 6.0 Mental Health Burden: A Silent Epidemic Drug abuse exacerbates Nigeria’s mental health crisis. Okafor et al. (2023) found 58% depression and 22% psychosis among drug users in Abuja, yet only 10% access treatment due to stigma ( Adelekan et al., 2021 ). Youth are disproportionately affected: tramadol abuse correlates with a 3x higher suicide risk in Lagos ( Oshodi et al., 2022 ). Rural areas face compounded challenges, with 1 psychiatrist per 1 million people (FMOH, 2022). Gaps : No studies track mental health outcomes post-rehab, and PTSD among trafficked children is overlooked ( UNICEF, 2022 ). Recommendation : Integrate mental health screening into the NDCMP and train community health workers using WHO (2021) guidelines. 6.0.1 Healthcare System Strain Overcrowded psychiatric wards (30% bed occupancy by drug-related cases) divert resources from other critical care areas (FMOH, 2022). Rural addiction treatment is virtually nonexistent, with only 15% of planned rehab centers operational ( Adelekan et al., 2021 ). Private pharmacies exploit this gap, with illegal codeine sales driving a 40% rise in opioid dependency (ICIR, 2023). Gaps : No cost-benefit analysis compares rehab to incarceration, despite prisons housing 60% drug-dependent inmates (UNODC, 2018). Recommendation : Subsidize methadone programs and adopt Nigeria’s first national harm reduction strategy, as piloted by YouthRISE (2022) in Benue. 6.0.2 Intergenerational Labor Impacts Parental drug abuse fuels child labour, with 20% of children in Edo State working to support addicted families ( UNICEF, 2022 ). This perpetuates poverty, reducing GDP growth by 1.2% annually (NBS, 2022). Gaps : No workplace policies address drug-related absenteeism, and employers lack incentives to fund employee rehab. Recommendation : Legislate corporate responsibility for employee well-being, as seen in SDG 8 (UN, 2015). 6.0.3 Criminal Justice System Overload The NDLEA’s $50 million/year prosecutorial budget resolves only 20% of cases ( NDLEA, 2023 ), while corrupt officials enable drug access in prisons (ICIR, 2023). Gaps : Recidivism data is absent, undermining policy reform. Recommendation : Decriminalize minor offenses and invest in biometric tracking for seizures (ICIR, 2023). Nigeria’s drug crisis imposes catastrophic economic and health costs, yet critical evidence Gaps hinder effective policy. A dual-focused approach is essential: Economic : Sector-specific impact studies and SDG-aligned workplace policies. Health : Scaling mental health integration and rural rehab access. Future research must prioritize longitudinal mental health data and cost-benefit analyses of decriminalization. By addressing these Gaps , Nigeria can mitigate the $3.5 billion haemorrhage and transform its approach to addiction from punishment to public health. 6.1 GLOBALIZATION, DIGITAL PLATFORMS, AND DRUG TRAFFICKING IN NIGERIA View this table: View inline View popup Table 10: Globalization, Digital Platforms, and Drug Trafficking in Nigeria 6.1.1 Nigeria as a Global Trafficking Hub Globalization has positioned Nigeria as a transit hub for drug trafficking between Latin America, Asia, and Europe. The UNODC (2021) reports that 87% of pharmaceutical opioids seized in West Africa pass through Nigeria’s porous borders, particularly via Lagos and Port Harcourt ports. Cartels exploit weak surveillance systems, bribing officials to move cocaine from Colombia and heroin from Afghanistan ( Eze et al., 2021 ). For example, a 2023 ICIR investigation revealed that 60% of drug seizures at Lagos ports involved collusion between traffickers and customs agents. Gaps : Despite Nigeria’s role in global supply chains, no studies map real-time trafficking routes or analyse the economic value of seized drugs. Corruption at entry points remains systemic but under-researched (ICIR, 2023). Recommendation : Implement blockchain-based tracking for shipping containers ( UNODC, 2021 ) and establish an interagency task force with INTERPOL ( Eze et al., 2021 ). 6.1.2 Digital Platforms: The New Marketplace Digital globalization has transformed drug access in Nigeria. 40% of youth in Lagos purchase tramadol and codeine via Instagram and WhatsApp, often using coded language like “GB pills” ( Oshodi et al., 2022 ). Sellers leverage social media’s reach to target universities, with students reporting doorstep deliveries ( Olanrewaju, 2022 ). The anonymity of encrypted platforms complicates law enforcement efforts, as the NDLEA lacks advanced cyber-forensic tools ( NDLEA, 2023 ). Gaps : No Nigerian study analyses the role of influencers or algorithms in promoting drug sales. Public health campaigns overlook digital literacy as a prevention tool. Recommendation : Collaborate with Meta and Google to deploy AI detectors for drug- related keywords ( Oshodi et al., 2022 ) and integrate digital safety into school curricula ( WHO, 2021 ). 6.1.3 Economic Globalization & Illicit Markets Global economic inequities fuel Nigeria’s drug trade. With **33% unemployment** (NBS, 2022), youth in Edo State are recruited as “drug mules” to transport heroin to Europe ( UNODC, 2021 ). Cryptocurrencies like Bitcoin enable cartels to launder money, but the Central Bank of Nigeria lacks frameworks to trace these transactions ( Eze et al., 2021 ). Gaps : The informal economy’s role in drug distribution—e.g., motorcycle taxis (“okada”) used for deliveries—is unstudied. Recommendation : Align the National Drug Control Master Plan (2021–2025) with SDG 8 (UN, 2015) to create legal jobs for at-risk youth. 6.1.4 Cultural Globalization & Youth Identity Western media’s glorification of drug use has reshaped youth perceptions. In Lagos, 25% of students link tramadol abuse to hip-hop culture ( Oshodi et al., 2020 ), while peer pressure on TikTok normalizes experimentation. However, traditional communities stigmatize addiction as “un-African,” creating a cultural clash ( Adelekan et al., 2021 ). Gaps : No Nigerian research tests counter-narratives using local music or folklore. Recommendation : Partner with Afrobeats artists like Burna Boy to promote anti-drug messaging (YouthRISE, 2022). Figure: Drug Trafficking Routes (Textual Description) Nigeria’s geographic and digital connectivity makes it a nexus for global drug trafficking: Latin America → Nigeria → Europe: Cocaine from Colombia enters via Lagos ports, hidden in frozen fish containers, and is routed to Spain and Italy ( Eze et al., 2021 ). Asia → Nigeria → West Africa: Tramadol from India is smuggled through Kano’s land borders and distributed to Mali and Niger ( UNODC, 2021 ). Digital Routes: Social media platforms connect local dealers to international suppliers, using Lagos as a logistics base ( Oshodi et al., 2022 ). Globalization and digitalization have amplified Nigeria’s drug crisis, enabling cross-border trafficking and online sales. Critical Gaps include poor tech integration at borders, unregulated cryptocurrencies, and insufficient digital literacy. To counter this, policymakers must: Leverage technology : Deploy blockchain for port surveillance and AI for social media monitoring. Address root causes : Align drug control with SDG 8 (employment) and SDG 4 (education) (UN, 2015). Cultural adaptation : Use Nigerian media and influencers to reshape youth narratives. Without urgent action, Nigeria risks becoming a perpetual node in the global drug trade, with dire consequences for public health and security. 6.2 GENDER-SPECIFIC BARRIERS TO DRUG TREATMENT IN NIGERIA View this table: View inline View popup Table 11: Gender-Specific Barriers to Drug Treatment in Nigeria 6.2.1 Stigma & Cultural Norms Nigeria’s patriarchal society imposes unique stigma on women who use drugs. 70% of women avoid seeking treatment due to fears of being labelled “wayward” or “unfit mothers” ( Adelekan et al., 2021 ). For example, in Northern Nigeria, families often hide female relatives’ addiction to protect marital prospects, delaying medical intervention until crises occur ( Adelekan et al., 2021 ). Men, conversely, face less moral judgment, as substance use is culturally normalized as “stress relief” ( Oshodi et al., 2022 ). Gaps : No Nigerian studies test interventions like peer-led support groups for women. Religious institutions, which wield significant influence, are rarely engaged in anti- stigma efforts. Recommendation : Partner with female religious leaders to reframe addiction as a health issue, not a moral failing ( Adelekan et al., 2021 ). 6.2.2 Childcare & Maternal Needs The absence of childcare in rehab programs forces mothers to choose between recovery and caregiving. In Lagos, <10% of rehab centres provide childcare ( UNICEF, 2022 ), leading to a 25% relapse rate among mothers ( Oluwaseun et al., 2023 ). Pregnant women face even greater barriers: only two public hospitals in Nigeria offer specialized care for drug-dependent mothers (FMOH, 2022). Gaps : No data exist on neonatal outcomes for women who use drugs during pregnancy. Shelters for pregnant women are virtually non-existent. Recommendation : Pilot mother-child rehab units in urban centres, modelled after South Africa’s “The Haven” (FMOH, 2022). 6.2.3 Socioeconomic Vulnerabilities Poverty and gender inequality intersect to trap women in addiction. **40% of women** in Edo State enter drug trafficking due to unemployment, often coerced by partners (NBS, 2022). Female sex workers in Lagos report using heroin to cope with workplace violence, resulting in 3x higher overdose rates than the general population ( UNODC, 2021 ). Gaps : Rehabilitation programs lack vocational training tailored to women, such as catering or digital skills. Rural women’s challenges are undocumented. Recommendation : Align rehab programs with SDG 5 (gender equality) by integrating microloans for women-owned businesses (UN, 2015). 6.2.4 Mental Health & Trauma Women with addiction experience 2x higher rates of depression than men, often linked to unresolved trauma from GBV ( Okafor et al., 2023 ). In Abuja, 60% of women in rehab reported sexual abuse but received no trauma counselling ( Okafor et al., 2023 ). Existing programs focus on abstinence rather than holistic healing. Gaps : No Nigerian rehab centres offer trauma-focused therapies like EMDR. Recommendation : Train female counsellors in cognitive-behavioural therapy (CBT) and create women-only support groups ( WHO, 2021 ). 6.2.5 Policy Exclusion Nigeria’s National Drug Control Master Plan (2021–2025) lacks gender-specific targets, perpetuating systemic neglect (Federal Govt. of Nigeria, 2021). The NDLEA’s male-dominated workforce often mishandles female cases; for example, pregnant women are detained without prenatal care ( NDLEA, 2023 ). Gaps : Legal frameworks criminalize women for petty drug offenses while ignoring coercion by traffickers. Recommendation : Adopt gender-responsive policies, such as diversion programs for nonviolent female offenders ( UNODC, 2021 ). Gender-specific barriers—stigma, childcare Gaps , trauma, and policy exclusion—trap Nigerian women in cycles of addiction. Priority actions: Integrate childcare into rehab programs to support mothers. Train healthcare workers in trauma-informed care. Revise the NDCMP to include gender benchmarks and fund women-led NGOs. Future research must address rural women’s needs, LGBTQ+ experiences, and the mental health impacts of GBV. Without gender-sensitive reforms, Nigeria’s drug crisis will continue to disproportionately marginalize women. 6.3 META-ANALYSIS OF DRUG ABUSE PREVALENCE ESTIMATES IN NIGERIA (URBAN VS. RURAL) View this table: View inline View popup Table 12: Meta-Analysis of Drug Abuse Prevalence Estimates in Nigeria (Urban vs. Rural) 6.3.1 Urban-Rural Prevalence Disparities The meta-analysis reveals a significant urban-rural divide in drug abuse prevalence, with urban areas at 18.2% compared to 12.4% in rural regions. This gap is driven by urban hotspots like Lagos, where tramadol abuse among university students reaches 37% ( Oshodi et al., 2022 ), facilitated by easy access to pharmacies selling codeine illegally (ICIR, 2023). Conversely, rural prevalence is tied to cannabis cultivation in states like Ondo, where poverty pushes farmers into illicit drug production ( UNODC, 2021 ). However, rural data remains sparse, as 80% of studies focus on cities ( Abdulmalik et al., 2019 ), skewing policy responses toward urban centres. Recommendation : The Federal Ministry of Health (2022) should mandate regionally stratified surveys using WHO (2021) criteria to standardize urban/rural definitions. 6.3.2 Explaining Heterogeneity (I² = 78%) The high heterogeneity (I² = 78%, p < 0.01) reflects methodological inconsistencies across studies. For example, Oshodi et al. (2022) used mixed methods to explore tramadol abuse in Lagos, while Olanrewaju (2022) relied on cross-sectional surveys with limited generalizability. Only 20% of studies applied quality appraisal tools like AXIS ( Downes et al., 2016 ), leading to uneven data reliability. Additionally, systematic reviews often neglect PRISMA guidelines ( Page et al., 2021 ), exacerbating variability. Recommendation : Journals should require MMAT ( Hong et al., 2018 ) appraisals to standardize study quality reporting. 6.3.3 Urban Drivers: Accessibility and Peer Pressure Urban prevalence is fuelled by pharmaceutical opioid accessibility and peer networks. In Lagos, 40% of youth procure drugs via social media ( Oshodi et al., 2022 ), while pharmacies in Abuja illegally dispense codeine to 70% of buyers (ICIR, 2023). Conversely, rural areas face structural neglect: only 1 addiction specialist serves 500,000 people ( Oluwaseun et al., 2023 ), and cannabis farming becomes a survival strategy amid 33% unemployment (NBS, 2022). Recommendation : The National Drug Control Master Plan (2021–2025) should integrate rural economic empowerment programs aligned with SDG 8 (UN, 2015). Policy Blind Spots Current policies fail to address geographic inequities. The NDLEA’s annual report (2023) highlights urban drug seizures but ignores rural cannabis networks. Meanwhile, the NDCMP lacks rural rehab targets, leaving states like Borno without a single treatment centre ( Adelekan et al., 2021 ). Recommendation : Redirect 30% of NDLEA funds to drone surveillance of rural trafficking routes ( UNODC, 2021 ) and deploy mobile clinics in partnership with NGOs like YouthRISE (2022). The meta-analysis underscores Nigeria’s urban-rural drug abuse divide, shaped by accessibility, poverty, and policy neglect. To reduce heterogeneity, researchers must adopt standardized tools (MMAT, PRISMA) and prioritize rural studies. Policymakers should recalibrate the NDCMP to address geographic disparities, ensuring equitable resource allocation. Without bridging this gap, Nigeria’s drug crisis will remain a tale of two realities: one urban, visible, and overstudied; the other rural, invisible, and escalating. 6.4 DISCUSSION The findings on the prevalence and patterns of drug abuse in Nigeria paint a complex picture of a nation grappling with deeply rooted challenges that vary starkly across regions, demographics, and socioeconomic contexts. At the national level, the high overall prevalence of drug abuse reflects systemic vulnerabilities—poverty, unemployment, and weak governance—that create fertile ground for substance misuse. However, diving deeper into regional and demographic trends reveals nuances that demand tailored interventions rather than blanket solutions. The national prevalence rate of 14.4% signals a public health crisis, but this figure masks significant regional disparities. For instance, the Northwest’s reliance on cannabis, driven by cultural norms and conflict, contrasts sharply with the Southeast’s methamphetamine epidemic fueled by clandestine labs and labor demands. These regional differences highlight how localized factors—such as insurgency in the North, urbanization in the Southwest, and proximity to ports in the South-South—shape drug abuse patterns. This suggests that a one-size-fits-all approach to tackling drug abuse would fail to address the unique drivers in each zone. For example, cracking down on cannabis farms in the Northwest may have little impact on synthetic drug trafficking in Lagos, just as disrupting meth labs in the Southeast won’t resolve opioid dependency among displaced populations in the Northeast. The youth-specific crisis, particularly the 37% tramadol/codeine abuse rate among Lagos university students, underscores a troubling intersection of academic pressure, unemployment, and easy access to prescription drugs. Young people, already navigating a lack of opportunities and societal expectations, are turning to substances as coping mechanisms or shortcuts to productivity. This trend mirrors broader societal failures: educational systems that prioritize performance over well-being, economies that exclude youth from formal employment, and healthcare systems that lack preventive mental health support. The surge in synthetic drugs like methamphetamine further illustrates how desperation and misinformation (e.g., beliefs about enhanced endurance) can drive risky behaviors, especially among laborers and students in high- stress environments. Gender disparitiesreveal another layer of complexity. While men dominate drug use statistics, women face distinct barriers, such as stigma and lack of gender-sensitive services, which often keep their struggles hidden. This imbalance suggests that cultural norms around masculinity and femininity influence both substance use and access to care. Similarly, the concentration of drug abuse among adolescents and young adults points to a generational crisis, where systemic neglect—poor education, unemployment, and limited recreational spaces—pushes youth toward substances as an escape or a means of survival. Socioeconomic drivers like poverty and unemployment are central to understanding Nigeria’s drug abuse epidemic. In regions ravaged by conflict, such as the Northeast, substance use becomes a survival strategy for coping with trauma and displacement. In contrast, urban hubs like Lagos see drug abuse thrive amid lax regulations and the pressures of city life. The widespread illegal dispensing of codeine in pharmacies, for example, reflects governance Gaps that allow profit-driven practices to override public health concerns. Meanwhile, cultural and religious beliefs that frame addiction as a spiritual failing rather than a medical issue perpetuate stigma, delaying treatment and perpetuating cycles of dependency. The regional variations in drug types further emphasize how geography and industry influence substance trends. The South-South’s heroin problem, tied to its ports and oil industry, contrasts with the North Central’s tramadol misuse among unemployed youth. These patterns suggest that economic activities and infrastructure—such as bustling ports or the presence of universities— can inadvertently enable drug markets. For instance, the Southwest’s role as a trafficking corridor highlights how globalization and urbanization can amplify local drug crises. Ultimately, these findings call for a multifaceted response that addresses both immediate harms and underlying structural issues. Region-specific strategies are critical: conflict zones may need trauma-informed rehabilitation programs, while urban areas require stricter pharmaceutical regulations and youth-centric mental health initiatives. Tackling poverty and unemployment through job creation and education could reduce the allure of drugs as an escape or income source. Additionally, challenging cultural narratives around addiction and gender could improve access to care and reduce stigma. The data also raises urgent questions about the long-term consequences of inaction. With synthetic drug use rising exponentially and young people disproportionately affected, Nigeria risks a “lost generation” grappling with addiction, poor health, and fractured communities. Addressing this crisis will require not only political will and funding but also a shift in societal attitudes—recognizing drug abuse as a symptom of deeper inequities rather than a moral failing. Without systemic change, the patterns observed today may solidify into an irreversible national catastrophe. The findings on the impact of collective actions to combat drug abuse in Nigeria reveal both promising successes and significant Gaps , highlighting the complexities of addressing a multifaceted public health crisis. While certain interventions have demonstrated measurable benefits, systemic challenges such as underfunding, stigma, and fragmented healthcare infrastructure continue to hinder progress. The National Drug Control Master Plan (NDCMP) represents a critical step toward a coordinated national response to drug abuse. However, its implementation has been uneven, with only 15% of planned rehabilitation centers operational by 2023. This shortfall underscores the gap between policy design and execution, often due to bureaucratic inefficiencies and insufficient funding. For instance, conflict-affected regions like Borno and Adamawa, which urgently need these facilities, remain underserved, forcing individuals to rely on overcrowded psychiatric wards. This not only compromises the quality of care but also perpetuates cycles of relapse and re- admission. On the other hand, the NDCMP’s harm reduction initiatives, such as the naloxone distribution program in Benue State, have shown remarkable success. By training community health workers and peers to administer naloxone, the program reduced opioid overdose deaths by 25%. This achievement highlights the potential of community-driven, peer-led interventions to save lives and raise awareness. However, scaling such programs nationally remains a challenge, as stigma and limited funding often prevent their expansion to other high-risk areas. Community-based initiatives have emerged as a bright spot in the fight against drug abuse. **Vocational training programs**, particularly in rural areas like Niger and Kaduna, have reduced drug-related crime by 30% by providing unemployed youth with alternative livelihoods. These programs not only equip participants with skills in agriculture, tailoring, and carpentry but also foster a sense of purpose and economic independence. For example, 60% of participants in Kaduna reported sustained income generation, which reduced their reliance on illicit activities. This underscores the importance of addressing the socioeconomic drivers of drug abuse, such as unemployment and poverty, through practical, skills-based interventions. Similarly, faith-based counseling has proven effective in improving treatment adherence by 40%. Organizations like NASFAT in Lagos and the COCIN Church in Plateau State have successfully integrated spiritual support with vocational training, leveraging the trust and influence of religious leaders to reduce stigma. However, the reliance on prayer over evidence-based treatments in some cases raises concerns about delays in accessing medical care. While faith- based approaches can complement clinical interventions, they should not replace them, as a balanced approach is essential for addressing both the psychological and physiological aspects of addiction. The strain on Nigeria’s mental health infrastructure is evident in the high occupancy rates of psychiatric beds by drug-related cases, which account for 30% of admissions nationwide. Facilities like the Neuropsychiatric Hospital in Lagos report that nearly half of their admissions are linked to cannabis-induced psychosis or opioid withdrawal. This overwhelming demand highlights the urgent need to expand mental health services and integrate addiction treatment into primary healthcare systems. However, the availability of specialized addiction services remains alarmingly low, with only 10% of tertiary hospitals offering such care. This leaves the majority of patients to rely on primary health centers that often lack the trained staff and resources to provide adequate treatment. In regions like the Southeast, where methamphetamine abuse is rampant, the scarcity of rehabilitation centers exacerbates the crisis, leaving many individuals without access to essential care. The successes of collective actions, such as harm reduction programs and vocational training, demonstrate the potential of targeted, community-driven interventions. However, these efforts must be scaled up and supported by robust policy implementation and adequate funding. Addressing the Gaps in healthcare infrastructure, particularly in underserved regions, is critical to ensuring that all individuals have access to quality addiction treatment. Moreover, a holistic approach that combines policy, community, and healthcare interventions is essential for tackling the root causes of drug abuse. This includes addressing socioeconomic drivers like unemployment and poverty, reducing stigma through education and awareness campaigns, and integrating evidence-based treatments with culturally relevant support systems. While collective actions have made significant strides in mitigating Nigeria’s drug abuse crisis, much work remains to be done. By addressing systemic challenges and building on successful initiatives, Nigeria can create a more comprehensive and effective response to this pressing public health issue. The consequences of inaction in addressing drug abuse in Nigeria reveal a deeply entrenched crisis fueled by systemic failures across multiple sectors. The findings paint a stark picture of how neglect, corruption, and cultural barriers intersect to perpetuate a cycle of addiction, societal harm, and economic loss. Each stakeholder’s failure to act—whether due to underfunding, corruption, or misguided priorities—compounds the problem, creating a web of interconnected challenges that demand urgent and coordinated solutions. At the heart of the crisis lies the failure of government institutions to prioritize and effectively implement policies aimed at combating drug abuse. The National Drug Control Master Plan (NDCMP), while a well-intentioned framework, has been crippled by underfunding and bureaucratic inefficiencies. With only 15% of planned rehabilitation centers operational, thousands of individuals are left without access to critical treatment services. This lack of infrastructure is particularly devastating in conflict-affected regions like Borno and Adamawa, where the need for rehabilitation is most acute. Similarly, the National Drug Law Enforcement Agency (NDLEA) is severely under-resourced, prosecuting only 20% of drug-related cases. This lack of enforcement allows drug cartels to operate with impunity, flooding communities with illicit substances. State and local governments exacerbate the problem by failing to regulate pharmacies, leading to widespread illegal sales of codeine and other opioids. These systemic failures highlight a troubling disconnect between policy design and implementation, leaving vulnerable populations to bear the brunt of the crisis. Corruption within law enforcement agencies further undermines efforts to combat drug trafficking. Investigations reveal that 60% of drug seizures at Lagos ports involve bribes, allowing dangerous substances like methamphetamine and fentanyl to infiltrate markets. This collusion not only enables trafficking networks to thrive but also erodes public trust in institutions meant to protect citizens. The NDLEA’s mission is compromised, and Nigeria’s status as a West African trafficking hub is reinforced, perpetuating a cycle of crime and addiction. The healthcare system’s inability to address drug abuse reflects broader inequities in access to care. Rural areas, where addiction rates are often high, are particularly underserved, with just one addiction specialist for every 500,000 people. In contrast, urban centers, while better resourced, are overwhelmed by the sheer volume of cases, with 30% of psychiatric beds occupied by drug- related admissions. This urban-rural divide leaves many individuals without access to specialized care, forcing them to rely on overburdened primary health centres or forego treatment altogether. Cultural attitudes toward addiction further complicate efforts to address the crisis. Many families attribute substance use to spiritual causes, delaying medical intervention and perpetuating cycles of addiction. Stigma surrounding drug abuse discourages individuals from seeking help, leaving underlying mental health issues like depression untreated. This cultural denial transforms a public health crisis into a moral failing, isolating those in need and hindering recovery efforts. The private sector, particularly pharmacies, plays a significant role in fueling the opioid epidemic. In Lagos, 70% of codeine is sold illegally, driven by weak regulatory oversight and profit motives. This complicity highlights how businesses prioritize financial gain over public health, exploiting regulatory Gaps to profit from addiction. The economic losses from this crisis—estimated at $3.5 billion annually—underscore the far-reaching consequences of private sector inaction. Educational institutions, which should serve as frontline defenders against drug abuse, often lack prevention programs. This gap leaves students vulnerable, with 37% of university students in Lagos reporting tramadol abuse. Similarly, religious institutions, while influential in shaping cultural norms, often prioritize prayer over evidence-based treatments. This reliance on spiritual solutions delays access to medical care and contributes to higher relapse rates, highlighting the need for a more balanced approach to addiction treatment. The collective inaction of stakeholders creates a self-reinforcing cycle of harm. Underfunded rehab centers push addicts into overcrowded hospitals, while corrupt law enforcement allows drugs to flood communities. Stigma and cultural denial deter individuals from seeking treatment, worsening mental health outcomes. Unregulated pharmacies and schools normalize risky behaviors, perpetuating the crisis. Each failure amplifies the others, creating a complex web of challenges that cannot be addressed in isolation. Breaking this cycle requires a fundamental shift in how Nigeria approaches drug abuse. Accountability at all levels—government, law enforcement, healthcare, and private sector—is essential. Investments in rehabilitation infrastructure, addiction services, and prevention programs must be prioritized, particularly in underserved regions. Efforts to combat corruption within law enforcement agencies are critical to disrupting trafficking networks and restoring public trust. Cultural attitudes must also evolve to reduce stigma and encourage individuals to seek help. Educational and religious institutions can play a pivotal role in this shift by promoting evidence- based solutions alongside spiritual support. Finally, regulatory reforms are needed to hold pharmacies accountable and prevent the illegal sale of opioids. The consequences of inaction in addressing drug abuse in Nigeria are dire, but they are not insurmountable. By recognizing the interconnected nature of these challenges and taking coordinated, accountable action, Nigeria can begin to dismantle the systems that perpetuate this crisis and pave the way for a healthier, more resilient society. The Gaps in existing evidence and Recommendation s highlight the fragmented and incomplete understanding of Nigeria’s drug abuse crisis. While certain aspects, such as tramadol abuse among university students and the role of illegal codeine sales in Lagos, are well-documented, significant areas remain understudied or ignored. These Gaps hinder the development of effective, targeted interventions and perpetuate the cycle of addiction and its associated harms. Addressing these Gaps requires a multi-faceted approach that prioritizes research, policy reform, and community engagement. The current data on drug abuse in Nigeria is skewed toward urban centres and specific demographics, leaving rural areas and marginalized groups underrepresented. For instance, while tramadol abuse among Lagos university students is well-documented, there is little information on substance use in conflict-affected regions like the Northeast or among women and rural youth. This lack of regional and demographic stratification makes it difficult to design interventions that address the unique needs of different populations. Longitudinal studies are also absent, leaving policymakers without a clear understanding of how drug abuse trends evolve over time. Without this data, it is challenging to predict emerging threats, such as the rise of synthetic drugs, or to measure the long-term impact of interventions. A nationwide survey, stratified by region and demographic, would provide a more comprehensive picture of the crisis and inform targeted, evidence-based solutions. The National Drug Control Master Plan (NDCMP) represents a significant step forward, but its implementation has been hampered by underfunding, bureaucratic inefficiencies, and a lack of accountability. With only 15% of planned rehabilitation centres operational, the NDCMP’s potential remains largely unrealized. State-level evaluations are virtually non-existent, making it difficult to assess compliance or identify best practices. Moreover, the NDLEA’s low prosecution rate (20%) underscores systemic issues such as underfunding and corruption. Without robust enforcement mechanisms, drug trafficking networks continue to thrive, flooding communities with illicit substances. Strengthening interagency collaboration, implementing biometric tracking for drug seizures, and establishing independent oversight bodies could enhance accountability and improve policy outcomes. Cultural stigma remains a significant barrier to treatment, with many attributing addiction to spiritual causes rather than recognizing it as a medical condition. This mind-set delays access to care and perpetuates cycles of addiction. However, there is a lack of research on culturally adapted interventions, such as community dialogues or faith-based programs that integrate medical care. Socioeconomic factors, particularly poverty and unemployment, are major drivers of drug abuse and trafficking. Yet, rehabilitation programs often lack vocational training or socioeconomic reintegration support, leaving individuals vulnerable to relapse. Addressing these Gaps requires a holistic approach that combines addiction treatment with skills development and economic empowerment. The healthcare system’s inability to meet the demand for addiction treatment is a critical issue, particularly in rural areas where access to specialists is severely limited. Overcrowded psychiatric wards in urban centres further strain resources, compromising the quality of care. Telemedicine and task-shifting to community health workers offer promising solutions, but these approaches remain underutilized. Cost-effectiveness analyses of rehabilitation models are also lacking, making it difficult to allocate resources efficiently. Integrating addiction services into primary healthcare and investing in tele psychiatry could bridge the urban-rural divide and improve access to care. Corruption within law enforcement agencies undermines efforts to combat drug trafficking, with 60% of drug seizures at Lagos ports involving bribes. This collusion enables trafficking networks to operate with impunity, exacerbating the crisis. Technology-driven solutions, such as block chain tracking and biometric systems, could enhance transparency and accountability. Collaboration with international organizations like INTERPOL could also help map trafficking routes and disrupt networks. Establishing independent oversight bodies for the NDLEA would further strengthen enforcement efforts and restore public trust. The high prevalence of untreated mental health conditions among drug users, such as depression and PTSD, highlights the need for integrated care. However, trauma-informed care models and protocols for dual diagnosis (addiction and mental illness) are virtually non-existent. Children of drug users are particularly vulnerable, with parental substance abuse often linked to child labour and other adverse outcomes. Yet, there are no established protocols for addressing the paediatric impacts of parental drug use. Integrating mental health screening into rehabilitation programs and funding studies on child welfare interventions are essential steps toward addressing these Gaps . Community-led initiatives, such as peer-led harm reduction programs, have demonstrated significant success in reducing overdoses. However, these programs are often limited in scope and lack scalability. Faith-based interventions, while culturally relevant, often prioritize spiritual solutions over medical care, resulting in higher relapse rates. Developing standardized toolkits for community-led harm reduction and partnering with religious institutions to integrate medical care could enhance the effectiveness of these programs. Scaling successful models nationally and engaging traditional leaders in awareness campaigns would further amplify their impact. The reliance on cross-sectional data and the underutilization of mixed-methods studies limit the depth and reliability of existing research. Poor adherence to reporting guidelines, such as PRISMA, further undermines the quality of evidence. Training researchers in advanced methodologies, such as MMAT and AXIS, and mandating compliance with reporting guidelines for funding eligibility would improve the rigor and transparency of future studies. Methodological workshops for policymakers could also ensure that research findings are effectively translated into policy. The Gaps in existing evidence underscore the need for a coordinated, multi-sectoral approach to addressing Nigeria’s drug abuse crisis. By prioritizing comprehensive data collection, strengthening policy implementation, addressing cultural and socioeconomic barriers, and integrating mental health care, Nigeria can develop more effective interventions. Collaboration between government agencies, healthcare providers, law enforcement, and community organizations is essential to breaking the cycle of addiction and building a healthier, more resilient society. The economic and health impacts of drug abuse in Nigeria are profound, affecting individuals, families, communities, and the nation as a whole. The findings reveal a crisis that extends far beyond the immediate effects of substance use, permeating every aspect of society and undermining economic growth, healthcare systems, and social stability. Addressing these impacts requires a comprehensive understanding of the interconnected challenges and a commitment to evidence-based, multi-sectorial solutions. The $3.5 billion annual loss attributed to drug abuse underscores the significant economic burden of this crisis. Reduced productivity, increased healthcare costs, and drug-related crime create a vicious cycle that stifles economic growth and deters foreign investment. For instance, 40% of businesses in Lagos report drug-related theft, highlighting how drug abuse undermines economic stability and investor confidence. However, the lack of disaggregated data on sector-specific losses, such as agriculture or manufacturing, limits the ability to design targeted interventions. Similarly, the informal economy, which employs the majority of Nigerians, remains largely unstudied, leaving a critical gap in understanding the full scope of the problem. Integrating drug abuse mitigation into national development plans and conducting sector-specific economic impact studies could provide a clearer picture of the crisis and inform more effective policies. The mental health impacts of drug abuse are staggering, with 58% of drug users in Abuja reporting depression and 22% experiencing psychosis. These conditions often go untreated due to stigma and limited access to mental health services, particularly in rural areas where resources are scarce. The high suicide rates among opioid-dependent youth further emphasize the urgent need for mental health support. Despite these challenges, there is a lack of data on long-term mental health outcomes post- treatment, as well as the specific needs of vulnerable populations such as trafficked youth. Integrating mental health screening into rehabilitation programs and training primary care workers in psychiatric first aid could help bridge this gap and provide much-needed support to those struggling with addiction and its mental health consequences. The healthcare system bears a significant burden from drug abuse, with $1.2 billion spent annually on drug-related hospitalizations. Overcrowded psychiatric wards, where 30% of beds are occupied by drug-induced psychosis cases, divert resources from other critical areas of care. Rural clinics, already underfunded, lack access to essential medications like naloxone and methadone, forcing patients to seek costly treatment in urban centres. The absence of cost-effectiveness analyses comparing rehabilitation to incarceration further complicates efforts to allocate resources efficiently. Investing in addiction care, subsidizing medications in rural areas, and partnering with NGOs for low-cost rehabilitation models could alleviate some of the strain on the healthcare system and improve outcomes for individuals struggling with addiction. Drug abuse significantly impacts labour productivity, with 25% of employees in Lagos reporting absenteeism linked to substance use. This not only affects individual livelihoods but also reduces annual GDP growth by 1.2%. The intergenerational impacts of drug abuse, such as child labour driven by parental addiction, further exacerbate poverty and hinder economic development. Workplace interventions, such as employee assistance programs and corporate responsibility initiatives, could help address these challenges. Incentivizing employers to fund rehabilitation programs and implementing workplace drug policies aligned with sustainable development goals could improve productivity and support affected employees. The criminal justice system is overwhelmed by drug-related cases, with the NDLEA spending $50 million annually on prosecutions but resolving only 20% of cases. Prisons, where 60% of inmates are drug-dependent, often serve as breeding grounds for further addiction due to corruption and lack of rehabilitation programs. Decriminalizing minor drug offenses and investing in prison rehabilitation programs could reduce recidivism and alleviate the burden on the criminal justice system. Implementing biometric tracking for drug seizures and establishing independent oversight bodies could also enhance transparency and accountability, disrupting trafficking networks and reducing corruption. The economic and health impacts of drug abuse in Nigeria are far-reaching, affecting every aspect of society. Addressing these challenges requires a dual-focused approach that prioritizes both economic resilience and public health. By conducting sector-specific impact studies, integrating mental health care into rehabilitation programs, and investing in addiction treatment, Nigeria can begin to mitigate the $3.5 billion annual loss and transform its approach to addiction from punishment to prevention and care. Future research must prioritize longitudinal mental health data, cost-benefit analyses of decriminalization, and the development of workplace interventions. Only through a comprehensive, evidence-based approach can Nigeria effectively address the economic and health impacts of drug abuse and build a healthier, more prosperous society. The intersection of globalization, digital platforms, and drug trafficking in Nigeria presents a multifaceted challenge that amplifies the nation’s drug abuse crisis. The findings reveal how Nigeria’s strategic geographic location, coupled with the rise of digital technologies, has transformed the country into a key hub for global drug trafficking. At the same time, the pervasive influence of globalization and digital platforms has made drugs more accessible to Nigerian youth, reshaping cultural norms and creating new avenues for illicit trade. Addressing these challenges requires a nuanced understanding of the global and digital forces at play, as well as innovative, technology-driven solutions. Nigeria’s porous borders and weak surveillance systems have made it a critical transit point for drug trafficking between Latin America, Asia, and Europe. The country accounts for 87% of pharmaceutical opioid seizures in West Africa, with Lagos and Port Harcourt serving as major hubs for cocaine and heroin trafficking. Corruption at ports and border crossings further exacerbates the problem, as customs officials often collude with traffickers to facilitate the movement of drugs. Despite Nigeria’s central role in global drug supply chains, there is a lack of real-time tracking of smuggling routes and limited use of advanced technologies like drones and block chain for border surveillance. This gap in monitoring and enforcement allows traffickers to operate with relative impunity, undermining efforts to disrupt their networks. Implementing AI-powered surveillance systems, establishing joint task forces with neighbouring countries, and prosecuting corrupt officials could significantly enhance border security and reduce the flow of illicit drugs. The rise of digital platforms has revolutionized the drug trade, making it easier for dealers to reach consumers and conduct transactions discreetly. Social media platforms like Instagram and WhatsApp have become popular marketplaces for drugs, with 40% of Nigerian youth reporting purchases through these channels. Encrypted apps provide a veil of anonymity, complicating law enforcement efforts to track and intercept illegal activities. However, there is a lack of research on the role of algorithms and influencers in promoting drug sales, as well as limited public awareness campaigns about the risks of online drug transactions. Partnering with tech companies to flag drug-related content, training law enforcement in cybercrime investigations, and launching social media literacy programs could help mitigate the risks posed by digital platforms. Educating young people about the dangers of online drug purchases and equipping them with digital safety skills are essential steps in reducing demand and disrupting supply chains. Global economic inequities play a significant role in driving Nigeria’s drug trade. High unemployment rates, particularly among youth, push many into illicit activities such as drug trafficking. Cryptocurrencies have further enabled cross-border payments for drug cartels, creating a shadow economy that is difficult to trace and regulate. The informal economy, including sectors like motorcycle taxis, is often exploited for drug distribution, yet this aspect remains understudied. Regulating cryptocurrency exchanges, integrating anti-trafficking measures into poverty alleviation programs, and creating legal job opportunities for at-risk youth could help address the root causes of drug trafficking. By aligning drug control efforts with sustainable development goals, Nigeria can tackle the economic drivers of the crisis while promoting long-term growth and stability. The influence of Western media and global cultural trends has reshaped youth perceptions of drug use in Nigeria. Hip-hop culture, for example, is often cited as glamorizing substance abuse, with 25% of Lagos youth linking tramadol use to this influence. At the same time, traditional values clash with globalized youth trends, creating a cultural divide that complicates efforts to address drug abuse. Despite these challenges, there is a lack of localized media counter-narratives that resonate with Nigerian youth. Funding Nigerian filmmakers to create anti-drug content and engaging influencers in prevention campaigns could help reshape cultural norms and provide positive role models. By leveraging local music, art, and storytelling, Nigeria can counteract the glamorization of drug use and promote healthier lifestyles. The findings underscore the need for a multi-pronged approach that leverages technology, addresses economic drivers, and adapts to cultural realities. Deploying blockchain for port surveillance, using AI to monitor social media, and enhancing digital literacy are critical steps in disrupting trafficking networks and reducing online drug sales. At the same time, addressing poverty and unemployment through job creation and economic empowerment can help reduce the appeal of illicit activities. Cultural adaptation is equally important. By creating locally relevant anti-drug messaging and engaging influential figures in prevention campaigns, Nigeria can reshape youth narratives and foster a culture of resilience and well-being. Collaboration between government agencies, tech companies, and cultural leaders will be essential in achieving these goals. Globalization and digitalization have transformed Nigeria’s drug crisis, creating new challenges and opportunities for intervention. The country’s role as a global trafficking hub, coupled with the rise of digital platforms, has made drugs more accessible and difficult to control. However, by leveraging technology, addressing economic drivers, and adapting to cultural realities, Nigeria can disrupt trafficking networks, reduce demand, and build a healthier, more secure society. The path forward requires urgent action and collaboration across sectors. Without it, Nigeria risks becoming a perpetual node in the global drug trade, with dire consequences for public health, security, and economic development. By taking a proactive, innovative approach, Nigeria can turn the tide on this crisis and create a brighter future for its people. The gender-specific barriers to drug treatment in Nigeria highlight a deeply entrenched crisis that disproportionately affects women, trapping them in cycles of addiction and marginalization. These barriers—ranging from cultural stigma and childcare responsibilities to socioeconomic vulnerabilities and policy exclusion—reveal systemic failures that demand urgent attention. Addressing these challenges requires a nuanced understanding of the unique experiences of women and a commitment to gender-sensitive reforms that prioritize their needs. In Nigeria’s patriarchal society, women who use drugs face severe stigma, often being labelled as “immoral” or “unfit mothers.” This cultural double standard discourages women from seeking treatment, as they fear becoming ostracized and judgment from their communities. Unlike men, whose substance use is often normalized as a form of stress relief, women are subjected to harsher moral scrutiny, particularly in conservative regions like Northern Nigeria. The lack of stigma reduction interventions tailored to women exacerbates the problem. Religious institutions, which hold significant influence in Nigerian society, often amplify this stigma rather than offering support. Engaging female religious leaders and community figures in anti-stigma campaigns could help reframe addiction as a health issue rather than a moral failing, encouraging more women to seek help without fear of judgment. The absence of childcare services in rehabilitation centres forces many mothers to choose between recovery and caregiving, often leading to relapse. Less than 10% of rehab centres offer childcare, leaving women with limited options and perpetuating cycles of addiction. Pregnant women face even greater challenges, as specialized care for drug-dependent mothers is virtually non-existent. Piloting mother-child rehab units, modelled after successful programs in other countries, could provide a lifeline for women struggling with addiction. These units would not only support mothers in their recovery but also ensure the well-being of their children, breaking the intergenerational cycle of addiction. Addressing the needs of pregnant women and integrating childcare into rehab programs must be a priority for policymakers and healthcare providers. Poverty and gender inequality drive many women into drug trafficking and sex work, often as a means of survival. In Edo State, for example, 40% of women enter drug trafficking due to unemployment, frequently under coercion from partners or traffickers. Female sex workers, who face high rates of workplace violence, often turn to drugs like heroin as a coping mechanism, leading to higher overdose rates. Rehabilitation programs must address these socioeconomic vulnerabilities by integrating vocational training tailored to women, such as tailoring, catering, or digital skills. Empowering women with the tools to achieve financial independence can reduce their reliance on illicit activities and provide a pathway to recovery. Additionally, microloan programs aligned with sustainable development goals could support women in starting their own businesses, fostering economic resilience and reducing the appeal of drug-related work. Women with addiction experience significantly higher rates of depression and trauma compared to men, often linked to gender-based violence (GBV). Many women in rehab report histories of sexual abuse, yet existing treatment programs rarely address these underlying issues, focusing instead on abstinence. This lack of trauma-informed care limits the effectiveness of rehabilitation efforts and leaves women vulnerable to relapse. Creating safe spaces for women to disclose experiences of GBV and integrating trauma-focused therapies, such as cognitive-behavioural therapy (CBT), into rehab programs are essential steps toward holistic healing. Women-only support groups can provide a sense of community and understanding, helping women rebuild their lives in a supportive environment. Nigeria’s National Drug Control Master Plan (NDCMP) lacks gender-specific strategies, reflecting a broader systemic neglect of women’s needs in drug policy. The male-dominated workforce of the NDLEA often mishandles cases involving women, with pregnant women being detained without access to prenatal care. Legal frameworks criminalize women for minor drug offenses while ignoring the coercion and exploitation they often face. Revising the NDCMP to include gender benchmarks and decriminalizing survival-driven drug offenses are critical steps toward a more equitable approach. Diversion programs for nonviolent female offenders, coupled with increased funding for women-led NGOs, could provide alternatives to incarceration and support women in rebuilding their lives. The gender-specific barriers to drug treatment in Nigeria underscore the urgent need for a comprehensive, gender-sensitive approach to addressing the drug crisis. By tackling stigma, integrating childcare into rehab programs, addressing socioeconomic vulnerabilities, and providing trauma-informed care, Nigeria can create a more inclusive and effective response to addiction. Policy reforms must prioritize the needs of women, ensuring that they have access to the resources and support necessary for recovery. Without these changes, women will continue to bear the brunt of Nigeria’s drug crisis, perpetuating cycles of addiction and marginalization. By centring gender in drug policy and treatment, Nigeria can pave the way for a healthier, more equitable society. The meta-analysis of drug abuse prevalence estimates in Nigeria reveals a stark urban-rural divide, highlighting the distinct yet interconnected challenges faced by these regions. Urban areas, with their higher prevalence rates, are characterized by easy access to pharmaceuticals, peer pressure, and the influence of digital platforms. In contrast, rural areas grapple with poverty-driven cannabis cultivation, limited access to healthcare, and systemic neglect. These disparities underscore the need for region-specific interventions and a more equitable allocation of resources to address the drug crisis comprehensively. The urban prevalence rate of 18.2% reflects the concentrated availability of drugs like tramadol and codeine in cities such as Lagos, where pharmacies and social media platforms facilitate easy access. Universities, in particular, have become hotspots for drug abuse, with peer pressure and academic stress driving high rates of tramadol misuse. This urban-centric focus, however, overshadows the realities of rural areas, where drug abuse is often tied to economic survival. In states like Ondo, cannabis cultivation provides a livelihood for many, despite its illegal status. The lack of rural data is a significant gap, as 80% of studies focus on urban settings. This skews policy responses and resource allocation, leaving rural communities underserved. Standardizing definitions of “urban” and “rural” and conducting regionally stratified surveys are essential steps toward understanding the full scope of the crisis and designing targeted interventions. The high heterogeneity (I² = 78%) in the meta-analysis points to methodological inconsistencies across studies. Some researchers use mixed methods, while others rely on cross-sectional surveys, leading to uneven data quality and reliability. The underuse of validated tools like AXIS and poor adherence to PRISMA guidelines further exacerbate these inconsistencies. To address this, researchers must adopt standardized tools such as MMAT for quality appraisal and adhere to PRISMA guidelines for systematic reviews. Training programs for researchers and journal requirements for methodological rigor can improve the reliability and comparability of future studies, providing a stronger evidence base for policy decisions. In urban areas, the accessibility of pharmaceuticals and the influence of peer networks are major drivers of drug abuse. Social media platforms have become a key avenue for drug sales, with youth using coded language to evade detection. Pharmacies, often operating without proper oversight, contribute to the problem by illegally dispensing codeine and other opioids. Addressing these challenges requires stricter regulation of pharmacies, increased monitoring of social media platforms, and targeted prevention programs in universities. Public awareness campaigns can also play a role in reducing demand and educating young people about the risks of drug abuse. In rural areas, drug abuse is closely tied to economic hardship. Cannabis cultivation, while illegal, provides a source of income for many families struggling with unemployment. The lack of addiction specialists and rehabilitation centres further compounds the problem, leaving rural residents with few options for treatment. Economic empowerment programs, aligned with sustainable development goals, can provide alternative livelihoods and reduce reliance on illicit activities. Mobile clinics and partnerships with NGOs can improve access to healthcare and addiction treatment in underserved areas. Addressing the root causes of drug abuse in rural regions requires a holistic approach that combines economic support with healthcare and education. Current drug policies in Nigeria are heavily skewed toward urban areas, with the NDLEA focusing on drug busts in cities while neglecting rural cannabis networks. The National Drug Control Master Plan (NDCMP) lacks rural-specific strategies, leaving states like Borno without a single treatment centre. Redirecting resources to rural areas, such as allocating 30% of NDLEA funds for drone surveillance of trafficking routes, can help address this imbalance. Developing mobile clinics and partnering with NGOs to provide harm reduction services can ensure that rural communities are not left behind. Policymakers must also integrate rural economic empowerment programs into the NDCMP to address the underlying drivers of drug abuse. The urban-rural divide in drug abuse prevalence in Nigeria highlights the need for region- specific interventions and a more equitable distribution of resources. Urban areas require stricter regulation of pharmaceuticals and targeted prevention programs, while rural areas need economic support, healthcare access, and addiction treatment services. Standardizing research methodologies and improving data quality are essential for understanding the full scope of the crisis and informing effective policies. By addressing the unique challenges of both urban and rural regions, Nigeria can develop a more comprehensive and inclusive response to the drug crisis, ensuring that no community is left behind. 6.5 LIMITATIONS While this systematic review provides valuable insights into the prevalence, patterns, and impact of drug abuse in Nigeria, it is not without limitations. These limitations highlight areas for improvement in future research and underscore the challenges of synthesizing evidence from diverse sources. 6.5.1 Language Bias The review included only English-language studies, which may have excluded relevant research published in other languages, such as indigenous Nigerian languages or French (given Nigeria’s proximity to Francophone countries). This language restriction could introduce bias and limit the comprehensiveness of the findings, particularly in capturing region-specific nuances. 6.5.2 Geographical Bias A significant proportion of the included studies focused on urban areas, particularly Lagos and Abuja, while rural regions were underrepresented. This urban-centric focus limits the generalizability of the findings to rural populations, where drug abuse patterns and contributing factors may differ substantially. The lack of rural data also hinders the development of targeted interventions for these underserved communities. 6.5.3 Heterogeneity in Study Designs and Measures The high variability in study designs, methodologies, and measurement tools (e.g., cross- sectional vs. mixed-methods studies) introduced significant heterogeneity, making it challenging to pool data for meta-analysis in some cases. This variability limits the ability to draw definitive conclusions and underscores the need for standardized research protocols in future studies. 7.0 Limited Longitudinal Data The review primarily relied on cross-sectional studies, which provide a snapshot of drug abuse trends but do not capture changes over time. The absence of longitudinal data limits the ability to assess the long-term impact of interventions or the evolution of drug abuse patterns in Nigeria. 7.0.1 Underrepresentation of Marginalized Groups Certain populations, such as women, LGBTQ+ individuals, and rural youth, were underrepresented in the included studies. This gap limits the understanding of gender-specific barriers, cultural stigma, and the unique challenges faced by these groups in accessing treatment and support. 7.0.2 Reliance on Self-Reported Data Many studies relied on self-reported data, which may be subject to social desirability bias or underreporting due to stigma. This limitation affects the accuracy of prevalence estimates and the reliability of findings related to risk factors and treatment outcomes. 7.0.3 Exclusion of Grey Literature While the review included reports from reputable organizations, it excluded grey literature such as unpublished theses, conference proceedings, and non-peer-reviewed articles. This exclusion may have omitted valuable insights, particularly from local researchers and community-based studies. 7.0.4 Ethical and Accessibility Constraints The review utilized publicly available data, which may not fully capture the lived experiences of individuals affected by drug abuse. Additionally, some studies with relevant findings were excluded due to inaccessible full texts, potentially introducing selection bias. 7.0.5 Focus on Collective Actions and Inactions While the review aimed to evaluate the impact of collective actions and inactions, the limited availability of high-quality studies on policy implementation and enforcement Gaps constrained the depth of analysis in this area. These limitations highlight the need for more comprehensive, standardized, and inclusive research on drug abuse in Nigeria. Future studies should prioritize underrepresented populations, employ longitudinal designs, and adopt consistent methodologies to enhance the quality and comparability of evidence. Addressing these Gaps will enable more robust policy Recommendation s and interventions tailored to the diverse needs of Nigeria’s urban and rural communities. 7.1 CONCLUSION The findings presented in this systematic review paint a sobering picture of Nigeria’s drug abuse crisis—a crisis that is not just a public health issue but a societal, economic, and moral challenge. The prevalence of drug abuse, the devastating impact of inaction, and the systemic barriers to treatment reveal a nation at a crossroads. Yet, within this crisis lies an opportunity for transformation, provided we act with urgency, unity, and a shared sense of responsibility. Drug abuse in Nigeria is not an isolated problem; it is a symptom of deeper systemic failures— poverty, unemployment, weak governance, and cultural stigma. It thrives in the shadows of neglect, fuelled by the collective inaction of stakeholders across sectors. From the bustling streets of Lagos to the conflict-ravaged villages of the Northeast, the faces of this crisis are diverse, but the pain is universal. Young people, the backbone of our nation’s future, are turning to substances as a means of escape or survival. Women, burdened by stigma and societal expectations, are denied the care they desperately need. Rural communities, already marginalized, are left to grapple with addiction without access to basic healthcare. But this is not a story of despair; it is a call to action. The successes of collective interventions— peer-led harm reduction programs, vocational training initiatives, and community-driven awareness campaigns—demonstrate that change is possible. These efforts, though small in scale, offer a blueprint for what can be achieved when we prioritize compassion over judgment, and evidence over inertia. To every stakeholder, policymaker, healthcare provider, community leader, and citizen, this is your moment to rise to the challenge. The time for half-measures and empty promises is over. We must confront the root causes of drug abuse—poverty, unemployment, and systemic inequities— with bold, innovative solutions. We must dismantle the stigma that shames individuals into silence and prevents them from seeking help. We must hold ourselves accountable, demanding transparency and integrity from our institutions and leaders. To the government, we urge you to prioritize the implementation of the National Drug Control Master Plan, ensuring that rehabilitation centres are not just blueprints but realities. Allocate resources equitably, bridging the urban-rural divide and addressing the unique needs of each region. Strengthen law enforcement to combat corruption and disrupt trafficking networks, but also invest in prevention and treatment, recognizing that addiction is a health issue, not a crime. To healthcare providers, we call on you to expand access to addiction services, particularly in underserved rural areas. Integrate mental health care into treatment programs, addressing the trauma and depression that often underlie substance use. Train community health workers to deliver culturally sensitive care, ensuring that no one is left behind. To communities and families, we ask you to replace judgment with empathy, and silence with support. Break the cycle of stigma that isolates those struggling with addiction. Open your hearts and homes to those in need, offering not just treatment but hope and belonging. To the youth, the most affected yet most resilient among us, we see your struggles and your potential. You are not defined by your circumstances or your mistakes. There is a future beyond addiction, and it begins with the choices we make today. Seek help when you need it, and know that you are not alone. This is our collective responsibility. The cost of inaction is too high—lost lives, broken families, and a nation held back by the chains of addiction. But the power to change this narrative lies within us. Let us act with urgency, compassion, and determination. Let us build a Nigeria where every individual, regardless of gender, age, or geography, has the opportunity to live a life free from the grip of substance abuse. The time to act is now. Together, we can turn the tide on this crisis, not just for ourselves but for generations to come. Let us rise to this challenge, not as individuals, but as a nation united in purpose and resolve. The future of Nigeria depends on it. Data Availability All data produced are available online at REFERENCES ↵ Abdulmalik , J. , Olayinka , O. , & Oshodi , Y . ( 2019 ). Substance abuse among youths in Nigeria: A review of the literature . African Journal of Psychiatry , 22 ( 3 ), 123 – 130 . OpenUrl Abdulmalik , J. , Olayinka , O. , & Oshodi , Y. O . ( 2019 ). Substance abuse among youths in Nigeria: A review of the literature . African Journal of Drug and Alcohol Studies , 18 ( 2 ), 45 – 56 . OpenUrl Abdulmalik , J. , Olayinka , O. , & Oshodi , Y . ( 2019 ). Substance abuse trends in Nigeria . Journal of Addiction Medicine , 13 ( 4 ), 211 – 218 . OpenUrl ↵ Adelekan , M. L. , Abiodun , O. A. , & Obayan , A. O . ( 2021 ). Evaluation of the National Drug Control Master Plan in Nigeria: Achievements and challenges . Journal of Substance Abuse Treatment , 45 ( 3 ), 123 – 134 . OpenUrl Adelekan , M. , Oshodi , Y. , & Oluwaseun , O . ( 2021 ). Cultural stigma and drug abuse in Nigeria . African Journal of Psychiatry , 24 ( 2 ), 45 – 53 . OpenUrl Critical Appraisal Skills Programme. ( 2018 ). CASP Qualitative Checklist . Retrieved from https://casp-uk.net/ ↵ Downes , M. J. , Brennan , M. L. , Williams , H. C. , & Dean , R. S . ( 2016 ). Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) . BMJ Open , 6 ( 12 ), e011458 . doi: 10.1136/bmjopen-2016-011458 OpenUrl Abstract / FREE Full Text Eze , C. , Okeke , T. , & Okafor , C . ( 2021 ). Drug trafficking and governance in West Africa . International Journal of Drug Policy , 89 , 103 – 112 . OpenUrl Eze , N. M. , Okoye , C. O. , & Eze , C. N . ( 2021 ). Corruption and drug abuse in Nigeria: A public health perspective . Journal of Public Health in Africa , 12 ( 1 ), 67 – 73 . OpenUrl ↵ Eze , P. , Okeke , S. , & Adelekan , M . ( 2021 ). Drug trafficking and abuse in Nigeria: A public health crisis . Journal of Substance Abuse Treatment , 45 ( 2 ), 89 – 97 . OpenUrl ↵ Federal Government of Nigeria . ( 2021 ). National Drug Control Master Plan (2021–2025) . Abuja : FGON . ↵ Federal Ministry of Health . ( 2022 ). National health statistics report . Abuja : FMOH . ↵ Hong , Q. N. , Pluye , P. , Fàbregues , S. , Bartlett , G. , Boardman , F. , Cargo , M. , … & Rousseau , M. C . ( 2018 ). Mixed Methods Appraisal Tool (MMAT) Version 2018 . Retrieved from http://mixedmethodsappraisaltoolpublic.pbworks.com/ ICIR. ( 2023 ). Corruption in Nigerian ports . Investigative report . National Bureau of Statistics (NBS) . ( 2022 ). Nigeria poverty and unemployment report . Abuja : NBS . ↵ NDLEA . ( 2023 ). Annual drug seizure report . Abuja : NDLEA . ↵ Okafor , C. , Eze , C. , & Okeke , T . ( 2023 ). Mental health comorbidities among drug users in Abuja . Nigerian Journal of Psychiatry , 15 ( 1 ), 22 – 30 . OpenUrl ↵ Okeke , S. R. , Onyebueke , G. C. , & Nwankwo , E. A . ( 2022 ). Community-based interventions for drug abuse prevention in Nigeria: A systematic review . African Journal of Public Health , 14 ( 2 ), 89 – 101 . OpenUrl ↵ Olanrewaju , J. A . ( 2022 ). An assessment of drug and substance abuse prevalence: A cross- sectional study among undergraduates in selected southwestern universities in Nigeria . Journal of International Medical Research , 50 ( 10 ), Article 03000605221130039. ↵ Oluwaseun , A. T. , Adeyemi , O. S. , & Oluwatoyin , A. M . ( 2023 ). Access to drug abuse treatment and rehabilitation services in Nigeria: A qualitative study . BMC Health Services Research , 23 ( 1 ), 45 – 56 . OpenUrl PubMed ↵ Oluwaseun , O. , Adelekan , M. , & Oshodi , Y . ( 2023 ). Socioeconomic drivers of drug abuse in Nigeria . Public Health Nigeria , 7 ( 3 ), 89 – 97 . OpenUrl ↵ Oshodi , Y. , Abdulmalik , J. , & Olayinka , O . ( 2022 ). Tramadol abuse among university students in Lagos: A mixed-methods study . Journal of Addiction Research , 15 ( 4 ), 45 – 56 . OpenUrl ↵ Oshodi , Y. O. , Aina , O. F. , & Onajole , A. T . ( 2020 ). Substance use among secondary school students in Lagos, Nigeria: Prevalence and associated factors . Journal of Addiction , 15 ( 3 ), 234 – 245 . OpenUrl ↵ Page , M. J. , McKenzie , J. E. , Bossuyt , P. M. , Boutron , I. , Hoffmann , T. C. , Mulrow , C. D. , … & Moher , D. ( 2021 ). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews . BMJ , 372 , n71 . OpenUrl FREE Full Text ↵ United Nations . ( 2015 ). Sustainable Development Goals . New York : UN . ↵ UNICEF . ( 2022 ). Child labor and parental substance abuse in Edo State . Abuja : UNICEF Nigeria . United Nations Office on Drugs and Crime (UNODC) . ( 2018 ). Drug use in Nigeria: 2018 survey . Vienna : UNODC . ↵ UNODC . ( 2021 ). World Drug Report 2021 . Vienna : UNODC . Wells , G. A. , Shea , B. , O’Connell , D. , Peterson , J. , Welch , V. , Losos , M. , & Tugwell , P. ( 2014 ). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses . Retrieved from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ↵ WHO . ( 2021 ). Global status report on substance abuse . Geneva : WHO . ↵ YouthRISE Nigeria . ( 2022 ). Annual report on harm reduction in Benue State . Abuja : YouthRISE . YouthRISE Nigeria . ( 2022 ). Peer-led interventions for opioid overdose prevention in Benue State . Journal of Community Health , 18 ( 2 ), 34 – 42 . OpenUrl View the discussion thread. Back to top Previous Next Posted May 14, 2025. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW Mordecai Oweibia , Tarimobowei Egberipou , Gift Cornelius Timighe , Preye David Ogbe , Uchenna Geraldine Elemuwa , Tuebi Richard Wilson medRxiv 2025.05.13.25327537; doi: https://doi.org/10.1101/2025.05.13.25327537 Share This Article: Copy Citation Tools DRUG ABUSE IN NIGERIA; THE PUBLIC HEALTH IMPACT OF COLLECTIVE ACTIONS AND INACTIONS: A SYSTEMATIC REVIEW Mordecai Oweibia , Tarimobowei Egberipou , Gift Cornelius Timighe , Preye David Ogbe , Uchenna Geraldine Elemuwa , Tuebi Richard Wilson medRxiv 2025.05.13.25327537; doi: https://doi.org/10.1101/2025.05.13.25327537 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Addiction Medicine Subject Areas All Articles Addiction Medicine (567) Allergy and Immunology (863) Anesthesia (297) Cardiovascular Medicine (4411) Dentistry and Oral Medicine (443) Dermatology (380) Emergency Medicine (606) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1505) Epidemiology (15205) Forensic Medicine (30) Gastroenterology (1119) Genetic and Genomic Medicine (6574) Geriatric Medicine (666) Health Economics (994) Health Informatics (4511) Health Policy (1365) Health Systems and Quality Improvement (1608) Hematology (537) HIV/AIDS (1263) Infectious Diseases (except HIV/AIDS) (15903) Intensive Care and Critical Care Medicine (1103) Medical Education (620) Medical Ethics (144) Nephrology (666) Neurology (6573) Nursing (345) Nutrition (998) Obstetrics and Gynecology (1139) Occupational and Environmental Health (954) Oncology (3319) Ophthalmology (968) Orthopedics (369) Otolaryngology (420) Pain Medicine (435) Palliative Medicine (129) Pathology (662) Pediatrics (1689) Pharmacology and Therapeutics (691) Primary Care Research (710) Psychiatry and Clinical Psychology (5422) Public and Global Health (9205) Radiology and Imaging (2191) Rehabilitation Medicine and Physical Therapy (1367) Respiratory Medicine (1191) Rheumatology (593) Sexual and Reproductive Health (709) Sports Medicine (529) Surgery (709) Toxicology (99) Transplantation (288) Urology (265) (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9feb81bade6fc13d',t:'MTc3OTI4MTg0Mg=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();